Cover Page
Cover Page - USD ($) $ in Billions | 12 Months Ended | ||
Dec. 31, 2023 | Feb. 13, 2024 | Jun. 30, 2023 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Document Quarterly Report | true | ||
Current Fiscal Year End Date | --12-31 | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Transition Report | false | ||
Entity File Number | 001-39540 | ||
Entity Registrant Name | Palantir Technologies Inc. | ||
Entity Incorporation, State or Country Code | DE | ||
Entity Tax Identification Number | 68-0551851 | ||
Entity Address, Address Line One | 1200 17th Street, Floor 15 | ||
Entity Address, City or Town | Denver | ||
Entity Address, State or Province | CO | ||
Entity Address, Postal Zip Code | 80202 | ||
City Area Code | (720) | ||
Local Phone Number | 358-3679 | ||
Title of 12(b) Security | Class A Common Stock, par value $0.001 per share | ||
Trading Symbol | PLTR | ||
Security Exchange Name | NYSE | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Interactive Data Current | Yes | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Small Business | false | ||
Entity Emerging Growth Company | false | ||
ICFR Auditor Attestation Flag | true | ||
Document Financial Statement Error Correction | false | ||
Entity Shell Company | false | ||
Entity Public Float | $ 29.3 | ||
Documents Incorporated by Reference | Documents Incorporated by Reference Portions of the registrant’s Definitive Proxy Statement relating to the Annual Meeting of Stockholders to be held in 2024 are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended December 31, 2023. | ||
Entity Central Index Key | 0001321655 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Amendment Flag | false | ||
Class A Common Stock | |||
Document Information [Line Items] | |||
Entity Common Stock, Shares Outstanding | 2,110,901,985 | ||
Class B Common Stock | |||
Document Information [Line Items] | |||
Entity Common Stock, Shares Outstanding | 100,826,007 | ||
Class F Common Stock | |||
Document Information [Line Items] | |||
Entity Common Stock, Shares Outstanding | 1,005,000 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2023 | |
Audit Information [Abstract] | |
Auditor Firm ID | 42 |
Auditor Name | Ernst & Young LLP |
Auditor Location | San Jose, California |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash and cash equivalents | $ 831,047 | $ 2,598,540 |
Marketable securities | 2,843,132 | 35,135 |
Accounts receivable, net | 364,784 | 258,346 |
Prepaid expenses and other current assets | 99,655 | 149,556 |
Total current assets | 4,138,618 | 3,041,577 |
Property and equipment, net | 47,758 | 69,170 |
Operating lease right-of-use assets | 182,863 | 200,240 |
Other assets | 153,186 | 150,252 |
Total assets | 4,522,425 | 3,461,239 |
Current liabilities: | ||
Accounts payable | 12,122 | 44,788 |
Accrued liabilities | 222,991 | 172,715 |
Deferred revenue | 246,901 | 183,350 |
Customer deposits | 209,828 | 141,989 |
Operating lease liabilities | 54,176 | 45,099 |
Total current liabilities | 746,018 | 587,941 |
Deferred revenue, noncurrent | 28,047 | 9,965 |
Customer deposits, noncurrent | 1,477 | 3,936 |
Operating lease liabilities, noncurrent | 175,216 | 204,305 |
Other noncurrent liabilities | 10,702 | 12,655 |
Total liabilities | 961,460 | 818,802 |
Commitments and Contingencies (Note 8) | ||
Stockholders’ equity: | ||
Common stock | 2,200 | 2,099 |
Additional paid-in capital | 9,122,173 | 8,427,998 |
Accumulated other comprehensive income (loss), net | 801 | (5,333) |
Accumulated deficit | (5,649,613) | (5,859,438) |
Total stockholders’ equity | 3,475,561 | 2,565,326 |
Noncontrolling interests | 85,404 | 77,111 |
Total equity | 3,560,965 | 2,642,437 |
Total liabilities and equity | $ 4,522,425 | $ 3,461,239 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - $ / shares | Dec. 31, 2023 | Dec. 31, 2022 |
Common stock, shares authorized (in shares) | 22,701,005,000 | 22,701,005,000 |
Common stock, shares issued (in shares) | 2,200,128,000 | 2,099,075,000 |
Common stock, shares outstanding (in shares) | 2,200,128,000 | 2,099,075,000 |
Class A Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 20,000,000,000 | 20,000,000,000 |
Common stock, shares issued (in shares) | 2,096,982,000 | 1,995,414,000 |
Common stock, shares outstanding (in shares) | 2,096,982,000 | 1,995,414,000 |
Class B Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 2,700,000,000 | 2,700,000,000 |
Common stock, shares issued (in shares) | 102,141,000 | 102,656,000 |
Common stock, shares outstanding (in shares) | 102,141,000 | 102,656,000 |
Class F Common Stock | ||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares authorized (in shares) | 1,005,000 | 1,005,000 |
Common stock, shares issued (in shares) | 1,005,000 | 1,005,000 |
Common stock, shares outstanding (in shares) | 1,005,000 | 1,005,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Revenue | $ 2,225,012 | $ 1,905,871 | $ 1,541,889 |
Cost of revenue | 431,105 | 408,549 | 339,404 |
Gross profit | 1,793,907 | 1,497,322 | 1,202,485 |
Operating expenses: | |||
Sales and marketing | 744,992 | 702,511 | 614,512 |
Research and development | 404,624 | 359,679 | 387,487 |
General and administrative | 524,325 | 596,333 | 611,532 |
Total operating expenses | 1,673,941 | 1,658,523 | 1,613,531 |
Income (loss) from operations | 119,966 | (161,201) | (411,046) |
Interest income | 132,572 | 20,309 | 1,607 |
Interest expense | (3,470) | (4,058) | (3,640) |
Other income (expense), net | (11,977) | (216,077) | (75,415) |
Income (loss) before provision for income taxes | 237,091 | (361,027) | (488,494) |
Provision for income taxes | 19,716 | 10,067 | 31,885 |
Net income (loss) | 217,375 | (371,094) | (520,379) |
Less: Net income attributable to noncontrolling interests | 7,550 | 2,611 | 0 |
Net income (loss) attributable to common stockholders | $ 209,825 | $ (373,705) | $ (520,379) |
Net earnings (loss) per share attributable to common stockholders, basic (in dollars per share) | $ 0.10 | $ (0.18) | $ (0.27) |
Net earnings (loss) per share attributable to common stockholders, diluted (in dollars per share) | $ 0.09 | $ (0.18) | $ (0.27) |
Weighted-average shares of common stock outstanding used in computing net earnings (loss) per share attributable to common stockholders, basic (in shares) | 2,147,446 | 2,063,793 | 1,923,617 |
Weighted-average shares of common stock outstanding used in computing net earnings (loss) per share attributable to common stockholders, diluted (in shares) | 2,297,927 | 2,063,793 | 1,923,617 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Statement of Comprehensive Income [Abstract] | |||
Net income (loss) | $ 217,375 | $ (371,094) | $ (520,379) |
Other comprehensive income (loss) | |||
Foreign currency translation adjustments | 2,699 | (2,984) | 396 |
Net unrealized gain (loss) on available-for-sale securities | 3,435 | 0 | 0 |
Comprehensive income (loss) | 223,509 | (374,078) | (519,983) |
Less: Comprehensive income attributable to noncontrolling interests | 7,550 | 2,611 | 0 |
Comprehensive income (loss) attributable to common stockholders | $ 215,959 | $ (376,689) | $ (519,983) |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Income (Loss), Net | Accumulated Deficit | Parent | Noncontrolling Interests |
Beginning balance (in shares) at Dec. 31, 2020 | 1,792,140,000 | ||||||
Beginning balance at Dec. 31, 2020 | $ 1,522,550 | $ 1,792 | $ 6,488,857 | $ (2,745) | $ (4,965,354) | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of common stock from the exercise of stock options (in shares) | 178,849,000 | ||||||
Issuance of common stock from the exercise of stock options | 507,455 | $ 178 | 507,277 | ||||
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares) | 50,350,000 | ||||||
Issuance of common stock upon vesting of restricted stock units (“RSUs”) | 0 | $ 50 | (50) | ||||
Issuance of common stock upon vesting of growth units (shares) | 1,471,000 | ||||||
Issuance of common stock upon vesting of growth units | 0 | $ 1 | (1) | ||||
Issuance of common stock upon net exercise of common stock warrants and other (in shares) | 4,664,000 | ||||||
Issuance of common stock upon net exercise of common stock warrants and other | 1,712 | $ 6 | 1,706 | ||||
Stock-based compensation | 779,296 | 779,296 | |||||
Other comprehensive income (loss) | 396 | 396 | |||||
Net income (loss) | (520,379) | (520,379) | |||||
Ending balance (in shares) at Dec. 31, 2021 | 2,027,474,000 | ||||||
Ending balance at Dec. 31, 2021 | 2,291,030 | $ 2,027 | 7,777,085 | (2,349) | (5,485,733) | $ 2,291,030 | $ 0 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of common stock from the exercise of stock options (in shares) | 19,660,000 | ||||||
Issuance of common stock from the exercise of stock options | 86,088 | $ 20 | 86,068 | 86,088 | |||
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares) | 51,941,000 | ||||||
Issuance of common stock upon vesting of restricted stock units (“RSUs”) | 0 | $ 52 | (52) | ||||
Stock-based compensation | 564,897 | 564,897 | 564,897 | ||||
Other comprehensive income (loss) | (2,984) | (2,984) | (2,984) | ||||
Noncontrolling interests | 74,500 | 74,500 | |||||
Net income (loss) | $ (371,094) | (373,705) | (373,705) | 2,611 | |||
Ending balance (in shares) at Dec. 31, 2022 | 2,099,075,000 | 2,099,075,000 | |||||
Ending balance at Dec. 31, 2022 | $ 2,642,437 | $ 2,099 | 8,427,998 | (5,333) | (5,859,438) | 2,565,326 | 77,111 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Issuance of common stock from the exercise of stock options (in shares) | 46,079,000 | 46,079,000 | |||||
Issuance of common stock from the exercise of stock options | $ 218,238 | $ 46 | 218,192 | 218,238 | |||
Issuance of common stock upon vesting of restricted stock units ("RSUs") (in shares) | 54,974,000 | ||||||
Issuance of common stock upon vesting of restricted stock units (“RSUs”) | 0 | $ 55 | (55) | ||||
Stock-based compensation | 476,038 | 476,038 | 476,038 | ||||
Other comprehensive income (loss) | 6,134 | 6,134 | 6,134 | ||||
Other, net | 743 | 743 | |||||
Net income (loss) | $ 217,375 | 209,825 | 209,825 | 7,550 | |||
Ending balance (in shares) at Dec. 31, 2023 | 2,200,128,000 | 2,200,128,000 | |||||
Ending balance at Dec. 31, 2023 | $ 3,560,965 | $ 2,200 | $ 9,122,173 | $ 801 | $ (5,649,613) | $ 3,475,561 | $ 85,404 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Operating activities | |||
Net income (loss) | $ 217,375 | $ (371,094) | $ (520,379) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||
Depreciation and amortization | 33,354 | 22,522 | 14,897 |
Stock-based compensation | 475,903 | 564,798 | 778,215 |
Deferred income taxes | (4,806) | (174) | 43,316 |
Noncash operating lease expense | 47,019 | 40,309 | 33,821 |
Unrealized and realized (gain) loss from marketable securities, net | 13,160 | 272,108 | 73,311 |
Noncash consideration | (46,609) | (15,537) | 0 |
Gain from step acquisition | 0 | (44,306) | 0 |
Other operating activities | (29,449) | 16,328 | 2,767 |
Changes in operating assets and liabilities, net of effect of acquisitions: | |||
Accounts receivable, net | (106,159) | (72,819) | (35,237) |
Prepaid expenses and other current assets | (6,197) | (24,811) | (10,974) |
Other assets | 3,242 | 6,033 | (3,345) |
Accounts payable | (31,832) | (29,859) | 57,767 |
Accrued liabilities | 52,895 | 5,527 | 15,245 |
Deferred revenue, current and noncurrent | 79,512 | (61,154) | 24,732 |
Customer deposits, current and noncurrent | 64,347 | (49,471) | (104,944) |
Operating lease liabilities, current and noncurrent | (49,630) | (34,590) | (32,156) |
Other noncurrent liabilities | 58 | (73) | (3,185) |
Net cash provided by operating activities | 712,183 | 223,737 | 333,851 |
Investing activities | |||
Purchases of property and equipment | (15,114) | (40,027) | (12,627) |
Purchases of marketable securities | (5,636,406) | (124,500) | (308,315) |
Proceeds from sales and redemption of marketable securities | 2,889,268 | 52,319 | 851 |
Business combinations, net of cash acquired | 0 | 66,708 | 0 |
Purchases of alternative investments | 0 | 0 | (50,941) |
Proceeds from sales of alternative investments | 51,072 | 0 | 0 |
Purchases of privately-held securities | 0 | 0 | (23,009) |
Other investing activities | 0 | 73 | (3,871) |
Net cash used in investing activities | (2,711,180) | (45,427) | (397,912) |
Financing activities | |||
Principal payments on borrowings | 0 | 0 | (200,000) |
Proceeds from the exercise of common stock options | 218,238 | 86,089 | 507,455 |
Other financing activities | 601 | (93) | (708) |
Net cash provided by financing activities | 218,839 | 85,996 | 306,747 |
Effect of foreign exchange on cash, cash equivalents, and restricted cash | 2,930 | (3,885) | (3,918) |
Net increase (decrease) in cash, cash equivalents, and restricted cash | (1,777,228) | 260,421 | 238,768 |
Cash, cash equivalents, and restricted cash - beginning of period | 2,627,335 | 2,366,914 | 2,128,146 |
Cash, cash equivalents, and restricted cash - end of period | 850,107 | 2,627,335 | 2,366,914 |
Supplemental disclosures of cash flow information | |||
Cash paid for income taxes | $ 13,515 | $ 2,904 | $ 4,131 |
Organization
Organization | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | Organization Palantir Technologies Inc. (including its subsidiaries, “Palantir” or the “Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms that serve as the central operating systems for its customers. |
Significant Accounting Policies
Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies Basis of Presentation and Consolidation The accompanying consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding annual financial reporting. The accompanying consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over, but does not control, the investee are accounted for using the equity method of accounting. Certain prior year balances have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, income (loss) from operations, net income (loss), or cash flows. The Company’s fiscal year ends on December 31. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying consolidated financial statements include, but are not limited to, the identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, and the collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. Segments The Company has two operating segments, commercial and government, which were determined based on the manner in which the chief operating decision maker (“CODM”), who is the Chief Executive Officer, manages the operations of the Company for purposes of allocating resources and evaluating performance. Various factors, including the Company’s organizational and management reporting structure and customer type, were considered in determining these operating segments. The Company’s operating segments are described below: • Commercial: This segment primarily serves customers working in non-government industries. • Government: This segment primarily serves customers that are United States (“U.S.”) government and non-U.S. government agencies. Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds and available-for-sale debt securities. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands): As of December 31, 2023 2022 2021 Cash and cash equivalents $ 831,047 $ 2,598,540 $ 2,290,674 Restricted cash included in prepaid expenses and other current assets 370 16,244 36,628 Restricted cash included in other assets 18,690 12,551 39,612 Total cash, cash equivalents, and restricted cash $ 850,107 $ 2,627,335 $ 2,366,914 Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The Company generally grants non-collateralized credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the Company’s assessment as of December 31, 2023 and 2022, the Company recorded an allowance for credit losses of $10.5 million and $10.1 million, respectively. Debt Securities Debt securities are primarily comprised of U.S. treasury securities. The debt securities are classified as available-for-sale at the time of purchase and are reevaluated as of each balance sheet date. The Company considers the majority of its available-for-sale debt securities as available for use in current operations and may sell these securities at any time, and therefore classifies these securities as current assets in its consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of U.S. treasury securities with original maturities of greater than three months at the time of purchase, and the remaining U.S. treasury securities are included in cash and cash equivalents. Interest income on debt securities is included in other income (expense), net on the consolidated statements of operations. The majority of the Company’s available-for-sale securities are recorded at fair value each reporting period using quoted prices of similar instruments and are classified within Level 2 of the fair value hierarchy. The Company evaluates investments with unrealized loss positions for other than temporary impairment by assessing if they are related to deterioration in credit risk and whether it expects to recover the entire amortized cost basis of the security, the Company’s intent to sell, and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their cost basis. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized in other income (expense), net in the consolidated statements of operations. Unrealized gains and non-credit related losses are reported as a separate component of accumulated other comprehensive loss, net in the consolidated balance sheets until realized. Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations. Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, marketable securities, and privately-held equity securities. Cash equivalents primarily consist of money market funds and U.S. treasury securities with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented in the consolidated balance sheets. The Company’s accounts receivable balances as of December 31, 2023 and 2022 were $364.8 million and $258.3 million, respectively. Customer I represented 15% of total accounts receivable as of December 31, 2023, and no other customer represented more than 10% of total accounts receivable as of December 31, 2023. No customer represented more than 10% of total accounts receivable as of December 31, 2022. For the years ended December 31, 2023, 2022, and 2021, no customer represented 10% or more of total revenue. Alternative Investments Alternative investments include gold bars and are recorded in prepaid expenses and other current assets on the consolidated balance sheets. The investments are initially recorded at cost and subsequently remeasured at the lower of cost or market each reporting period. Market value is determined by using quoted market prices of identical or similar assets from active markets. Unrealized losses are recorded in other income (expense), net in the consolidated statements of operations. Realized gains and losses are recorded in other income (expense), net upon realization. Property and Equipment, Net Property and equipment, net are stated at cost less accumulated depreciation and amortization. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets, which are generally three years. Leasehold improvements are capitalized and amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful life, which is generally five years. Maintenance and repairs that do not improve or extend the useful lives of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation and amortization are derecognized from the consolidated balance sheets and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized. Privately-held Equity Securities Equity securities in privately-held companies without readily determinable fair values are recorded using the measurement alternative. Such investments are carried at cost, less any impairments, and are adjusted for subsequent observable price changes in orderly transactions for identical or similar investments of the same issuer. Changes in the basis of the equity securities are recognized in other income (expense), net in the consolidated statements of operations. Business Combinations Business combinations are accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, and are included in our consolidated financial statements from their respective acquisition dates. Assets acquired and liabilities assumed, if any, are measured at fair value on the acquisition date using the appropriate valuation method. Goodwill generated from acquisitions is recognized if the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. In determining the fair value of identifiable assets, we use various valuation techniques which require us to make estimates and assumptions surrounding projected revenues and costs, future growth, and discount rates. Goodwill Goodwill represents the excess of the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests over the net fair value of the identifiable assets acquired and the liabilities assumed in business combinations. Goodwill is not amortized but is subject to an annual impairment test. We perform our annual goodwill impairment assessment on the first day of the fourth quarter. Tests are performed more frequently if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Goodwill is recorded in other assets in the consolidated balance sheet. Other Intangible Assets Other intangible assets include finite-lived intangible assets, which mainly consist of customer relationships, reacquired rights, and backlog. These assets are amortized over their estimated useful lives and are tested for impairment using a similar methodology to our property and equipment, as described below. Other intangible assets are recorded in other assets in the consolidated balance sheets. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparing the carrying amount of an asset to the future undiscounted cash flows that the asset is expected to generate. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Impairments of long-lived assets during the years ended December 31, 2023, 2022, and 2021 were not material. Leases The Company determines if an arrangement is a lease at inception. An arrangement is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If a lease is identified, classification is determined at lease commencement. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The Company’s leases do not provide an implicit interest rate and therefore the Company estimates its incremental borrowing rate to discount lease payments. The incremental borrowing rate reflects the interest rate that the Company would have to pay to borrow on a collateralized basis an amount equal to the lease payments in a similar economic environment over a similar term. Operating lease right-of-use (“ROU”) assets are based on the corresponding lease liability adjusted for any lease payments made at or before commencement, initial direct costs, and lease incentives. Renewals or early terminations are not accounted for unless the Company is reasonably certain to exercise these options. Operating lease expense is recognized and the ROU asset is amortized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For short-term leases, defined as leases with a term of twelve months or less, the Company elected the practical expedient to not recognize an associated lease liability and ROU asset. Lease payments for short-term leases are expensed on a straight-line basis over the lease term. Operating leases are included in operating lease right-of-use assets, operating lease liabilities, and operating lease liabilities, non-current on the Company’s consolidated balance sheets. Finance leases are not material. Fair Value Measurement Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The Company measures fair value based on a three-level hierarchy of inputs, maximizing the use of observable inputs, where available, and minimizing the use of unobservable inputs when measuring fair value. A financial instrument’s level within the three-level hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three-level hierarchy of inputs is as follows: Level 1: Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on the Company’s own assumptions about current market conditions and require significant management judgment or estimation. Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, marketable securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Revenue Recognition The Company generates revenue from the sale of subscriptions to access its software platforms in the Company’s hosted environment, along with ongoing operations and maintenance (“O&M”) services (“Palantir Cloud”); software licenses, primarily term licenses in the customers’ environments, with ongoing O&M services (“On-Premises Software”); and professional services. In accordance with ASC 606, Revenue from Contracts with Customers , the Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company applies the following five-step revenue recognition model in accounting for its revenue arrangements: • Identification of the contract(s) with the customer, including whether collectability of the consideration is probable by considering the customers’ ability and intention to pay; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Additionally, the pricing of the Company’s contracts is generally fixed; however, it is possible for contracts to include variable consideration, which can be based on subjective or objective criteria. The Company includes the estimated amount of variable consideration that it expects to receive to the extent it is probable that a significant revenue reversal will not occur. Each of the Company’s significant performance obligations and the Company’s application of ASC 606 to its revenue arrangements is discussed in further detail below. Palantir Cloud The Company’s Palantir Cloud subscriptions grant customers the right to access the software functionality in a hosted environment controlled by Palantir and are sold together with stand-ready O&M services, as further described below. The Company agrees to provide continuous access to its hosted software platforms throughout the contract term. Revenue associated with Palantir Cloud subscriptions is generally recognized over the contract term on a ratable basis, which is consistent with the transfer of control of the Palantir Cloud subscription to the customer. On-Premises Software Sales of the Company’s software licenses, primarily term licenses, grant customers the right to use functional intellectual property, either on their internal hardware infrastructure or on their own cloud instance, over the contractual term and are also sold together with stand-ready O&M services. The O&M services include critical updates, support, and maintenance services required to operate the software and, as such, are necessary for the software to maintain its intended utility over the contractual term. Because of this requirement, the Company has concluded that the software licenses and O&M services, which together the Company refers to as On-Premises Software, are highly interdependent and interrelated and represent a single distinct performance obligation within the context of the contract. Revenue is generally recognized over the contract term on a ratable basis. Professional Services The Company’s professional services support the customers’ use of the software platforms and include, as needed, on-demand user support, user-interface configuration, training, and ongoing ontology and data modeling support. Professional services contracts typically include the provision of on-demand professional services for the duration of the contractual term. These services are typically coterminous with a Palantir Cloud subscription or the On-Premises Software. Professional services are on-demand, whereby the Company performs services throughout the contract period; therefore, the revenue is recognized over the contractual term. Contract Liabilities The timing of customer billings and payments relative to the start of the service period varies from contract to contract; however, the Company bills many of its customers in advance of the provision of services under its contracts, resulting in contract liabilities consisting of either deferred revenue or customer deposits (“contract liabilities”). Deferred revenue represents billings under noncancelable contracts before the related product or service is transferred to the customer. Customer deposits consist of amounts billed and/or paid in advance of the start of the contractual term or for anticipated revenue generating activities for the portion of a contract term that is subject to cancellation by its customers. Many of the Company’s arrangements include terms that allow the customer to terminate the contract for convenience and receive a pro-rata refund of the amount of the customer deposit for the period of time remaining in the contract term after the applicable termination notice period expires. In these arrangements, the Company concluded there are no enforceable rights and obligations after such notice period and therefore the consideration received or due from the customer that is subject to termination for convenience is recorded as customer deposits. The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component. Areas of Judgment and Estimation The Company’s contracts with customers can include multiple promises to transfer goods or services to the customer. Determining whether promises are distinct performance obligations that should be accounted for separately – or not distinct within the context of the contract and, thus, accounted for together – requires significant judgment. The Company concluded that the promise to provide a software license is highly interdependent and interrelated with the promise to provide O&M services and such promises are not distinct within the context of its contracts and are accounted for as a single performance obligation as the Company’s On-Premises Software. Significant estimates and assumptions are used in the identification of performance obligations in customer contracts and collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect our financial position and results of operations. Costs to Obtain and Fulfill Contracts Incremental costs of obtaining a contract include only those costs that are directly related to the acquisition of contracts, including sales commissions, and that would not have been incurred if the contract had not been obtained. The Company recognizes a contract cost asset for the incremental costs of obtaining a contract with a customer if it is expected that the economic benefit and amortization period will be longer than one year. Costs to obtain contracts were not material in the periods presented. The Company recognizes an asset for the costs to fulfill a contract with a customer if the costs are specifically identifiable, generate or enhance resources used to satisfy future performance obligations, and are expected to be recovered. Costs to fulfill contracts were not material in the periods presented. Software Development Costs The Company evaluates capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company’s product development process and substantial development risks, technological feasibility is generally established for the Company’s products when they are made available for general release. Accordingly, most costs are charged to research and development expense in the period incurred. Cost of Revenue Cost of revenue primarily includes salaries, stock-based compensation expense, and benefits for personnel involved in performing O&M and professional services, as well as field service representatives, third-party cloud hosting services, travel costs, allocated overhead, and other direct costs. Sales and Marketing Costs Sales and marketing costs primarily include salaries, stock-based compensation expense, commissions, and benefits for the sales force and personnel involved in sales functions, executing on pilots, including bootcamps, and performing other brand building and customer growth activities, as well as third-party cloud hosting services for pilots, marketing and sales event-related costs, travel costs, and allocated overhead. The Company generally charges all such costs to sales and marketing expense in the period incurred. Advertising costs are expensed as incurred and included in sales and marketing expense within the consolidated statements of operations. Advertising expense totaled $21.4 million, $38.6 million, and $26.3 million for the years ended December 31, 2023, 2022, and 2021, respectively. Research and Development Costs Research and development costs primarily include salaries, stock-based compensation expense, and benefits for personnel involved in performing the activities to develop and refine the Company’s platforms and products, as well as third-party cloud hosting services and other IT related costs, travel costs, and allocated overhead. Research and development costs are expensed as incurred. Commitments and Contingencies Liabilities for loss contingencies arising from claims, disputes, legal proceedings, fines and penalties, and other sources are recorded when it is probable that a liability has been or will be incurred and the amount of the liability can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred. Recoveries of such legal costs from insurance policies are recorded as an offset to legal expenses in the period they are received. Stock-Based Compensation The Company accounts for stock-based compensation expense in accordance with the fair value recognition and measurement provisions of GAAP, which require compensation cost for the grant-date fair value of stock-based awards to be recognized over the requisite service period. The Company determines the fair value of stock-based awards granted or modified on the grant date or modification date using appropriate valuation techniques. The Company recognizes forfeitures as they occur. Service-Based Vesting The Company grants RSUs and stock option awards that vest based upon the satisfaction of only a service condition. For RSUs, the Company determines the grant-date fair value of the RSUs as the fair value of the Company’s common stock on the grant date. The Company records stock-based compensation expense for stock options and RSUs that vest based upon the satisfaction of only a service condition on a straight-line basis over the requisite service period, which is generally one Performance-Based Vesting The Company also grants awards, including RSUs, that vest upon the satisfaction of both a service condition and a performance condition. The Company determines the grant-date fair value of RSUs with both a service-based vesting condition and a performance-based vesting condition as the fair value of the Company’s common stock on the grant date and records stock-based compensation expense using the accelerated attribution method over the service period. The performance-based vesting condition for the RSUs granted prior to September 30, 2020, the date the Company completed a direct listing of its Class A common stock on the New York Stock Exchange (the “Direct Listing”) was satisfied upon the occurrence of the Company’s Direct Listing. For performance-based RSUs granted after the Direct Listing (“P-RSUs”), the Company recognizes expense from the number of P-RSUs expected to vest, determined based on the level of achievement against certain performance conditions, over the requisite service period when it is probable that the performance condition will be achieved. The probability of achievement is assessed periodically to determine whether the performance metric continues to be probable. When there is a change in the assessment of the probability of achievement, any cumulative effect of the change is recognized in the period of the change and any remaining expense of the related awards is amortized over the remaining service period. Employee Benefit Plan The Company sponsors a 401(k) tax-deferred savings plan for all employees who meet certain eligibility requirements. Participants may contribute, on a pretax and post-tax basis, a percentage of their qualifying annual compensation, but not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company may make additional matching contributions on behalf of the participants. The Company did not make matching contributions for the years ended December 31, 2023, 2022, and 2021. Income Taxes The Company estimates its current tax expense together with assessing temporary differences resulting from differing treatment of items not currently deductible for tax purposes. These differences result in deferred tax assets and liabilities on the Company’s consolidated balance sheets, which are estimated based upon the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates that will be in effect when these differences reverse. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the Company’s consolidated statements of operations become deductible expenses under applicable income tax laws or loss or credit carryforwards are utilized. Accordingly, the realization of the Company’s deferred tax assets is dependent on future taxable income against which these deductions, losses, and credits can be utilized. The Company evaluates the realizability of its deferred tax assets and recognizes a valuation allowance when it is more likely than not that a future benefit on such deferred tax assets will not be realized. The Company considers all evidence, both positive and negative, in determining any required valuation allowance and evaluates the need for a valuation allowance on a regular basis. The Company performs an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. The Company reviews the recognition of deferred tax assets on a regular basis to determine if realization of such assets is more likely than not. A valuation |
Contract Liabilities and Remain
Contract Liabilities and Remaining Performance Obligations | 12 Months Ended |
Dec. 31, 2023 | |
Revenue from Contract with Customer [Abstract] | |
Contract Liabilities and Remaining Performance Obligations | Contract Liabilities and Remaining Performance Obligations Contract Liabilities The Company’s contract liabilities consist of deferred revenue and customer deposits. As of December 31, 2023 and 2022, the Company’s contract liability balances were $486.3 million and $339.2 million, respectively. Revenue of $329.4 million and $384.3 million was recognized during the years ended December 31, 2023 and 2022, respectively, that was included in the contract liabilities balances as of December 31, 2022 and 2021, respectively. Remaining Performance Obligations The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company allows many of its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation. The Company’s remaining performance obligations were $1.2 billion as of December 31, 2023, of which the Company expects to recognize approximately 52% as revenue over the next 12 months, 37% as revenue over the subsequent 13 to 36 months, and the remainder thereafter. Disaggregation of Revenue See Note 13. Segment and Geographic Information for disaggregated revenue by customer segment and geographic region. |
Investments and Fair Value Meas
Investments and Fair Value Measurements | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Investments and Fair Value Measurements | Investments and Fair Value Measurements The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation (in thousands): As of December 31, 2023 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 576,565 $ 576,565 $ — $ — U.S. treasury securities 10,079 — 10,079 — Certificates of deposit 938 — 938 — Prepaid expenses and other current assets and other assets: Certificates of deposit 4,777 — 4,777 — Marketable securities: U.S. treasury securities 2,824,861 — 2,824,861 — Publicly-traded equity securities 18,271 18,271 — — Total $ 3,435,491 $ 594,836 $ 2,840,655 $ — As of December 31, 2022 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 1,149,302 $ 1,149,302 $ — $ — Certificates of deposit 6,791 — 6,791 — Prepaid expenses and other current assets and other assets: Certificates of deposit 18,707 — 18,707 — Marketable securities: Publicly-traded equity securities 35,135 35,135 — — Total $ 1,209,935 $ 1,184,437 $ 25,498 $ — Certificates of Deposit The Company’s certificates of deposit are Level 2 instruments. The fair value of such instruments is estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Debt Securities As of December 31, 2023, available-for-sale debt securities consisted of the following (in thousands): As of December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 2,831,505 $ 4,520 $ (1,085) $ 2,834,940 Total debt securities $ 2,831,505 $ 4,520 $ (1,085) $ 2,834,940 Included in cash and cash equivalents $ 10,078 $ 1 $ — $ 10,079 Included in marketable securities $ 2,821,427 $ 4,519 $ (1,085) $ 2,824,861 The Company sold $694.6 million of available-for-sale debt securities during the fiscal year ended December 31, 2023 and immediately reinvested such proceeds into additional available-for-sale debt securities. The realized gains and losses from those sales were immaterial. No credit or non-credit losses related to available-for sale debt securities were recorded as of December 31, 2023. As of December 31, 2023, available-for-sale debt securities of $236.0 million were in an unrealized loss position primarily due to unfavorable changes in interest rates subsequent to initial purchase. None of the available-for-sale debt securities held as of December 31, 2023 were in a continuous unrealized loss position for greater than 12 months. The decline in fair value below amortized cost basis was not considered other than temporary as it is more likely than not that the Company will hold the securities until maturity or a recovery of the cost basis, and no credit-related impairment losses were recorded as of December 31, 2023. All of the Company’s U.S. treasury securities had contractual maturities due within one year as of December 31, 2023. As of December 31, 2022, the Company held an immaterial amount of debt securities. Equity Securities The Company has equity securities consisting of shares held in publicly-traded companies, which are recorded at fair market value each reporting period within marketable securities in the consolidated balance sheets. Additionally, we have accepted, and may continue to accept, securities as noncash consideration. Total equity securities received as noncash consideration was $41.7 million, $6.8 million, and an immaterial amount during the years ended December 31, 2023, 2022, and 2021, respectively. Realized and unrealized gains and losses are recorded in other income (expense), net in the consolidated statements of operations. During the years ended December 31, 2022 and 2021, the Company recorded net unrealized losses of $159.0 million and $72.8 million, respectively, and realized losses of $113.1 million and an immaterial amount during the years ended December 31, 2022 and 2021, respectively, for its publicly-traded equity securities. For the years ended December 31, 2023, 2022, and 2021 net unrealized losses from publicly-traded equity securities held at the end of each period were $4.5 million, $197.3 million, and $72.8 million respectively. The Company also has equity securities in privately-held companies without readily determinable fair values that are recorded using the measurement alternative. As of December 31, 2023 and December 31, 2022, the total amount of privately-held equity securities included in other assets on the consolidated balance sheets was $32.6 million and $24.4 million, respectively. The Company classifies these fair value measurements as Level 3 within the fair value hierarchy. The Company did not record any material adjustments or impairments for the privately-held equity securities held as of December 31, 2023 and December 31, 2022. Investments From 2021 through 2022, the Company approved and entered into certain agreements (“Investment Agreements”) to purchase shares of various entities, including special purpose acquisition companies and/or other privately-held or publicly-traded entities (each, an “Investee,” and such purchases, the “Investments”). During the year ended December 31, 2022, the Company purchased shares for a total investment of $124.5 million. No Investments were purchased under such Investment Agreements during the fiscal year ended December 31, 2023. In connection with signing the Investment Agreements, each Investee or an associated entity and the Company entered into a commercial contract for access to the Company’s products and services (collectively, the “Strategic Commercial Contracts”). The Company assesses the concurrent agreements under the noncash and consideration paid or payable to a customer guidance within ASC 606, Revenue from Contracts with Customers, as well as the commercial substance of each arrangement considering the customer’s ability and intention to pay as well as the Company’s obligation to perform under each contract. As currently assessed, the total value of Strategic Commercial Contracts was $376.5 million as of December 31, 2023, which is inclusive of $40.4 million of contractual options. The original terms of the Strategic Commercial Contracts with remaining deal value as of December 31, 2023, including contractual options, range from two years to seven years and are subject to termination for cause provisions. The Company performs ongoing assessments of customers’ financial condition, including the consideration of customers’ ability and intention to pay, and whether all or some portion of the value of such contracts continue to meet the criteria for revenue recognition, among other factors. As of December 31, 2023, the cumulative amount of revenue recognized from Strategic Commercial Contracts was $253.9 million, of which $87.3 million of revenue was recognized during the year ended December 31, 2023. Alternative Investments During the year ended December 31, 2021, the Company purchased $50.9 million in 100-ounce gold bars. During the year ended December 31, 2023, the Company sold all of its gold bars for total proceeds of $51.1 million and recorded an immaterial realized gain within other income (expense), net in the consolidated statements of operations. |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Dec. 31, 2023 | |
Balance Sheet Related Disclosures [Abstract] | |
Balance Sheet Components | Balance Sheet Components Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of December 31, 2023 2022 Leasehold improvements $ 83,139 $ 80,378 Computer equipment, software, and other 50,844 52,688 Furniture and fixtures 13,834 13,010 Construction in progress 2,099 5,506 Total property and equipment, gross 149,916 151,582 Less: accumulated depreciation and amortization (102,158) (82,412) Total property and equipment, net $ 47,758 $ 69,170 Depreciation and amortization expense related to property and equipment, net was $23.7 million, $19.5 million, and $12.8 million for the years ended December 31, 2023, 2022, and 2021, respectively. Accrued Liabilities Accrued liabilities consisted of the following (in thousands): As of December 31, 2023 2022 Accrued payroll and related expenses $ 83,094 $ 43,495 Accrued taxes 47,257 41,326 Accrued other liabilities 92,640 87,894 Total accrued liabilities $ 222,991 $ 172,715 |
Debt
Debt | 12 Months Ended |
Dec. 31, 2023 | |
Debt Disclosure [Abstract] | |
Debt | Debt 2014 Credit Facility In October 2014, the Company entered into an unsecured revolving credit facility, which has been subsequently secured by substantially all of the Company’s assets and amended from time to time (as amended, the “2014 Credit Facility”). As of December 31, 2023, the Company had no outstanding debt balances and had undrawn revolving commitments of $500.0 million available to fund working capital and general corporate expenditures under the 2014 Credit Facility, which has a maturity date of March 31, 2027. The 2014 Credit Facility contains customary representations and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of December 31, 2023. |
Leases
Leases | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Leases | Leases The Company has operating leases primarily for corporate office space and equipment . Certain lease agreements contain renewal options, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate. The Company's leases have remaining terms up to December 2033, some of which include one or more options to extend. Additionally, some lease contracts include termination options. Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands): As of December 31, Lease-Related Assets and Liabilities Financial Statement Line Items 2023 2022 Right-of-use assets: Operating leases Operating lease right-of-use assets $ 182,863 $ 200,240 Total right-of-use assets $ 182,863 $ 200,240 Lease liabilities: Operating leases Operating lease liabilities $ 54,176 $ 45,099 Operating lease liabilities, noncurrent 175,216 204,305 Total lease liabilities $ 229,392 $ 249,404 The components of lease expense included in the Company's consolidated statements of operations include (in thousands): Years Ended December 31, 2023 2022 Operating lease expense $ 61,972 $ 55,483 Short-term lease expense 4,949 4,956 Variable lease expense 4,772 5,309 Sublease income (18,905) (13,011) Total lease expense, net $ 52,788 $ 52,737 Variable lease costs are primarily related to payments made to lessors for common area maintenance, property taxes, insurance, and other operating expenses. Short-term lease costs primarily represent temporary employee housing. Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands): As of December 31, 2023 Operating Lease Commitments Less: Sublease Income Net Lease Commitments Year ended December 31, 2024 $ 67,420 $ 16,593 $ 50,827 2025 57,053 14,357 42,696 2026 40,068 13,748 26,320 2027 28,278 14,423 13,855 2028 21,816 12,470 9,346 Thereafter 62,116 30,761 31,355 Total undiscounted liabilities 276,751 102,352 174,399 Less: Imputed interest (47,359) — (47,359) Total operating lease liabilities $ 229,392 $ 102,352 $ 127,040 The weighted-average remaining lease term related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was six years and seven years, respectively. The weighted-average discount rate related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was 6%. The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands): Years Ended December 31, 2023 2022 Cash paid for operating lease liabilities $ 63,374 $ 53,772 Lease liabilities arising from obtaining right-of-use assets $ 28,112 $ 28,169 |
Leases | Leases The Company has operating leases primarily for corporate office space and equipment . Certain lease agreements contain renewal options, rent abatement, and escalation clauses that are factored into our determination of lease payments when appropriate. The Company's leases have remaining terms up to December 2033, some of which include one or more options to extend. Additionally, some lease contracts include termination options. Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands): As of December 31, Lease-Related Assets and Liabilities Financial Statement Line Items 2023 2022 Right-of-use assets: Operating leases Operating lease right-of-use assets $ 182,863 $ 200,240 Total right-of-use assets $ 182,863 $ 200,240 Lease liabilities: Operating leases Operating lease liabilities $ 54,176 $ 45,099 Operating lease liabilities, noncurrent 175,216 204,305 Total lease liabilities $ 229,392 $ 249,404 The components of lease expense included in the Company's consolidated statements of operations include (in thousands): Years Ended December 31, 2023 2022 Operating lease expense $ 61,972 $ 55,483 Short-term lease expense 4,949 4,956 Variable lease expense 4,772 5,309 Sublease income (18,905) (13,011) Total lease expense, net $ 52,788 $ 52,737 Variable lease costs are primarily related to payments made to lessors for common area maintenance, property taxes, insurance, and other operating expenses. Short-term lease costs primarily represent temporary employee housing. Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands): As of December 31, 2023 Operating Lease Commitments Less: Sublease Income Net Lease Commitments Year ended December 31, 2024 $ 67,420 $ 16,593 $ 50,827 2025 57,053 14,357 42,696 2026 40,068 13,748 26,320 2027 28,278 14,423 13,855 2028 21,816 12,470 9,346 Thereafter 62,116 30,761 31,355 Total undiscounted liabilities 276,751 102,352 174,399 Less: Imputed interest (47,359) — (47,359) Total operating lease liabilities $ 229,392 $ 102,352 $ 127,040 The weighted-average remaining lease term related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was six years and seven years, respectively. The weighted-average discount rate related to the Company’s operating lease liabilities as of December 31, 2023 and 2022 was 6%. The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands): Years Ended December 31, 2023 2022 Cash paid for operating lease liabilities $ 63,374 $ 53,772 Lease liabilities arising from obtaining right-of-use assets $ 28,112 $ 28,169 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Purchase Commitments In September 2023, the Company amended one of its third-party cloud hosting services agreements. Under this amendment, the Company has a commitment to spend at least $1.95 billion over ten Litigation and Legal Proceedings From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company establishes an accrual for loss contingencies when the loss is both probable and reasonably estimable. On September 15, 2022, October 25, 2022, and November 4, 2022, putative securities class action complaints were filed in the United States District Court for the District of Colorado, captioned Cupat v. Palantir Technologies Inc., et al., Case No. 1:22-cv-02384, Allegheny County Employees’ Retirement System v. Palantir Technologies, Inc., et al., Case No. 1:22-cv-02805, and S hijun Liu, Individually and as Trustee of the Liu Family Trust 2019 v. Palantir Technologies Inc., et al., Case No. 1:22-cv-02893, respectively, naming the Company and certain current and former officers and directors as defendants. The suits allege false and misleading statements about our business and prospects, and purport to allege claims under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Securities Act of 1933, as amended (the “Securities Act”), and seek unspecified damages and remedies under Sections 10(b), 20(a), and 20(A) of the Exchange Act and Sections 11 and 15 of the Securities Act. These three actions subsequently were consolidated as Cupat v. Palantir Technologies Inc., et al., Lead Civil Action No. 1:22-cv-02834-CNS-SKC, consolidated with civil actions 1:22-cv-02805-CNS-SKC and 1:22-cv-02893-CNS-SKC. On November 21, 2022 and January 13, 2023, stockholder derivative actions were filed in the United States District Court for the District of Colorado, captioned Li v. Karp, et al., Case No. 22-cv-3028 and Parmenter v. Karp, et al., Case No. 23-cv-118, and on January 27, 2023, a stockholder derivative action was filed in the United States District Court for the District of Delaware captioned Miao v. Karp, et al., Case No. 1:23-cv-00103-MN, each against certain current and former officers and directors asserting breach of fiduciary duty and related claims relating to the allegations of the securities class action complaints and seek unspecified damages and injunctive remedies under Section 14(a) of the Exchange Act and Delaware law. On August 22, 2023, a stockholder derivative action was filed in the Court of Chancery of the State of Delaware captioned Central Laborers’ Pension Fund v. Karp, et al. , Case No. 2023-0864 against certain current and former officers and directors asserting breach of fiduciary duty and related claims relating to the allegations of the securities class action complaints and seeks unspecified damages and injunctive relief under Delaware law. Because the litigation is in early stages, the Company is unable to estimate the reasonably possible loss or range of loss, if any, that may result from these matters. On November 20, 2023, the plaintiff in Parmenter v. Karp, et al ., Case No. 23-cv-118, filed a Notice of Voluntary Dismissal. On November 28, 2023, the court terminated the Parmenter action accordingly. As of December 31, 2023, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that are expected to have a material adverse impact on its consolidated financial statements. Warranties and Indemnification The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer, and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of December 31, 2023 and 2022. The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of December 31, 2023 and 2022. The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s Amended and Restated Bylaws and Amended and Restated Certificate of Incorporation. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | 9. Stockholders’ Equity The Company’s Class A, Class B, and Class F common stock (collectively, the “common stock”) all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has the voting rights generally described herein and each share of Class F common stock is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held in a voting trust established by Stephen Cohen, Alexander Karp, and Peter Thiel (the “Founders”). The Class F common stock generally gives the Founders the ability to control up to 49.999999% of the total voting power of the Company’s capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100.0 million of the Company's equity securities as of December 31, 2023. Holders of the common stock are entitled to dividends when, as, and if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of December 31, 2023. The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of December 31, 2023 As of December 31, 2022 Authorized Issued and Outstanding Authorized Issued and Outstanding Class A Common Stock 20,000,000 2,096,982 20,000,000 1,995,414 Class B Common Stock 2,700,000 102,141 2,700,000 102,656 Class F Common Stock 1,005 1,005 1,005 1,005 Total 22,701,005 2,200,128 22,701,005 2,099,075 Share Repurchase Program |
Stock-Based Compensation
Stock-Based Compensation | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation 2020 Executive Equity Incentive Plan In August 2020, the Company’s Board of Directors approved the 2020 Executive Equity Incentive Plan (the “Executive Equity Plan”). The Executive Equity Plan permitted the granting of nonstatutory stock options (“NSOs”) and RSUs to the Company’s employees, consultants, and directors. A total of 165,900,000 shares of the Company’s Class B common stock were reserved for issuance under the Executive Equity Plan. During August 2020, options to purchase 162,000,000 shares of Class B common stock and restricted stock units covering 3,900,000 shares of the Company’s Class B common stock were granted to certain officers. The Executive Equity Plan was terminated prior to the Company’s Direct Listing, and no additional awards will be granted under the Executive Equity Plan. However, the Executive Equity Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the Executive Equity Plan. 2020 Equity Incentive Plan In September 2020, prior to the Direct Listing, the Company’s Board of Directors approved the 2020 Equity Incentive Plan (“2020 Plan”). The 2020 Plan provides for the grant of incentive stock options (“ISOs”), NSOs, restricted stock, RSUs, stock appreciation rights (“SARs”), and performance awards to the Company’s employees, directors, and consultants. A total of 150,000,000 shares of the Company’s Class A common stock were initially reserved for issuance pursuant to the 2020 Plan. In addition, the number of shares of Class A common stock reserved for issuance under the 2020 Plan includes certain shares of common stock subject to awards under the 2010 Equity Incentive Plan (“2010 Plan”) and Executive Equity Plan in the case of certain occurrences, such as expirations, terminations, exercise and tax-related withholding, or failures to vest. Shares of Class B common stock added to the 2020 Plan from the 2010 Plan or Executive Equity Plan are reserved for issuance under the Company’s 2020 Plan as Class A common stock. The number of shares of Class A common stock available for issuance under the 2020 Plan will also include an annual increase on the first day of each fiscal year beginning on January 1, 2022, equal to the least of: • 250,000,000 shares of the Company’s Class A common stock; • Five percent of the outstanding shares of the Company’s common stock as of the last day of the immediately preceding fiscal year; or • such other amount as the administrator of the 2020 Plan determines. Under the 2020 Plan, the exercise price of options granted is generally at least equal to the fair market value of the Company’s Class A common stock on the date of grant. The term of an ISO generally may not exceed ten years. Additionally, the exercise price of any ISO granted to a 10% stockholder shall not be less than 110% of the fair market value of the common stock on the date of grant, and the term of such option grant shall not exceed five years. Options and other equity awards become vested and, if applicable, exercisable based on terms determined by the Board of Directors or another plan administrator on the date of grant, which is typically four years for new employees and varies for subsequent grants. Stock Options The following table summarizes stock option activity for the year ended December 31, 2023 (in thousands, except per share amounts): Options Outstanding Weighted-Average Exercise Price Per Share Weighted-Average Aggregate Intrinsic Value Balance as of December 31, 2022 326,913 $ 8.05 8.33 $ 272,603 Options exercised (46,079) 4.74 Options canceled and forfeited (2,364) 5.39 Balance as of December 31, 2023 278,470 $ 8.62 7.64 $ 2,381,172 Options vested and exercisable as of December 31, 2023 160,877 $ 6.66 6.93 $ 1,691,404 The aggregate intrinsic value of options outstanding, and vested and exercisable is calculated as the difference between the exercise price of the underlying options and the fair value of the Company’s common stock as of December 31, 2023. The aggregate intrinsic value of options exercised during the years ended December 31, 2023, 2022, and 2021 was $476.8 million, $112.3 million, and $3.8 billion, respectively, and is calculated based on the difference between the exercise price and the fair value of the Company’s common stock on the exercise date. There were no options granted during the years ended December 31, 2023, 2022, and 2021. The total grant-date fair value of options that vested during the years ended December 31, 2023, 2022, and 2021 was $131.0 million, $170.8 million, and $189.5 million, respectively . As of December 31, 2023, the total unrecognized stock-based compensation expense related to options outstanding was $599.1 million, which is expected to be recognized over a weighted-average service period of seven years. RSUs and P-RSUs The following table summarizes the RSU and P-RSU activity for the year ended December 31, 2023 (in thousands, except per share amounts): RSUs P-RSUs Units Outstanding Weighted Average Grant Date Fair Value per Share Units Outstanding Weighted Average Grant Date Fair Value per Share Unvested and outstanding as of December 31, 2022 126,426 $ 10.07 — $ — Granted 19,484 11.77 1,976 15.39 Vested (54,974) 9.57 — — Canceled (8,674) 11.08 — — Unvested and outstanding as of December 31, 2023 82,262 $ 10.71 1,976 $ 15.39 During the fiscal year ended December 31, 2023, the Company granted RSUs that have only a service-based vesting condition, as well as those that have both service-based and performance-based vesting conditions (“P-RSUs”). The service-based vesting condition for each is generally satisfied upon continued service through a specified date. Vesting periods for the RSUs and P-RSUs are generally up to 4 years and three months, respectively. The performance-based vesting condition is satisfied upon the achievement of certain Company performance goals set by the Compensation Committee of the Board of Directors. The ultimate number of P-RSUs earned and eligible to vest ranges between 0% to 100% of the target number of P-RSUs granted depending on the level of achievement of such Company performance goals. The total grant-date fair value of RSUs vested during the years ended December 31, 2023, 2022, and 2021 was $526.1 million, $453.2 million, and $421.0 million, respectively. As of December 31, 2023, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $566.4 million, which is expected to be recognized over a weighted-average service period of three years. As of December 31, 2023, there was no unrecognized stock-based compensation expense related to the P-RSUs outstanding. Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Cost of revenue $ 35,995 $ 44,061 $ 68,546 Sales and marketing 160,645 196,301 242,910 Research and development 98,064 93,871 150,298 General and administrative 181,199 230,565 316,461 Total stock-based compensation expense $ 475,903 $ 564,798 $ 778,215 The Company did not recognize any tax benefits related to stock-based compensation expense during the years ended December 31, 2023, 2022, or 2021. |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Income (loss) before provision for income taxes consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 United States $ 174,637 $ (402,834) $ (514,200) Foreign 62,454 41,807 25,706 Income (loss) before provision for income taxes $ 237,091 $ (361,027) $ (488,494) Provision for income taxes consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 Current: Federal $ — $ — $ — State 2,333 765 (88) Foreign 22,189 9,476 (11,343) Total current provision 24,522 10,241 (11,431) Deferred: Federal — — (111) State — — — Foreign (4,806) (174) 43,427 Total deferred provision (4,806) (174) 43,316 Total provision for income taxes $ 19,716 $ 10,067 $ 31,885 A reconciliation of the expected tax provision at the statutory federal income tax rate to the Company’s recorded tax provision consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 Expected tax (benefit) at U.S. federal statutory rate $ 49,789 $ (75,592) $ (102,584) State income taxes - net of federal benefit 2,309 766 (88) Foreign tax rate differential 859 832 870 Research and development tax credits (45,667) (34,546) (94,591) Stock-based compensation (79,128) 1,374 (817,839) Non-deductible officers’ compensation 34,479 40,629 428,682 Change in valuation allowance 35,070 49,833 616,572 Base Erosion Anti-Abuse Tax and related elections 14,700 25,200 — Taxes withheld at source 4,378 — — Non-deductible expenses 3,610 — — Other (683) 1,571 863 Total provision for income taxes $ 19,716 $ 10,067 $ 31,885 For the year ended December 31, 2023, the Company recorded a provision for income taxes of $19.7 million compared to $10.1 million for the year ended December 31, 2022, primarily due to the increase in foreign income taxes as the result of higher foreign taxable income and higher foreign withholding taxes in the current year. The Company maintains a full valuation allowance against its U.S. federal and state, and certain foreign deferred tax assets. For the year ended December 31, 2022, the Company recorded a provision for income taxes of $10.1 million compared to $31.9 million for the year ended December 31, 2021, primarily due to the prior year establishment of a full valuation allowance against its U.K. deferred tax assets during the fourth quarter of 2021 partially offset by permanent differences associated with U.S. Base Erosion and Anti Abuse Tax elections. The Company maintains a full valuation allowance against its U.S. federal and state and certain foreign deferred tax assets. Deferred tax assets and liabilities are recognized for the future tax consequences of differences between the carrying amounts of assets and liabilities and their respective tax basis using enacted tax rates in effect for the year in which the differences are expected to reverse. Significant deferred tax assets and liabilities consisted of the following (in thousands): As of December 31, 2023 2022 Net operating loss carryforwards $ 1,317,684 $ 1,436,957 Capitalized research and experimental expenses 214,848 70,839 Reserves and accruals 99,105 76,905 Tax credit carryforwards 277,060 226,565 Stock-based compensation 139,419 203,735 Lease liabilities 53,902 58,056 Depreciation and amortization 14,413 29,665 Capitalized facilitative expenses 28,906 — Gross deferred tax assets 2,145,337 2,102,722 Outside basis difference — (6,512) Acquisition related intangibles (8,428) (10,225) Right-of-use assets (42,721) (46,295) Total net deferred tax assets before valuation allowance 2,094,188 2,039,690 Valuation allowance (2,102,251) (2,051,655) Net deferred tax assets (liabilities) $ (8,063) $ (11,965) Because of the Company’s history of U.S. and certain foreign net operating tax losses, primarily in the U.K., the Company has maintained a full valuation allowance against potential future benefits for U.S, federal, state, and certain foreign deferred tax assets as of December 31, 2023. The valuation allowance totaled $2.1 billion for the years ended December 31, 2023 and 2022. The valuation allowance on our net deferred tax assets increased by $50.6 million and $74.1 million during the years ended December 31, 2023 and 2022, respectively. Provisions enacted by the 2017 Tax Cuts and Jobs Act related to the capitalization for tax purposes of research and experimental (“R&E”) expenditures became effective on January 1, 2022. All U.S. and foreign based R&E expenditures must be capitalized and amortized over five years and 15 years, respectively. As a result of this enactment, the Company began capitalizing and amortizing R&E expenditures over five years for domestic research and 15 for foreign research rather than expensing these costs as incurred during fiscal year ended December 31, 2022. The Company has recorded a deferred tax asset of $214.8 million as of December 31, 2023 related to the capitalization requirement. As of December 31, 2023, the Company had U.S. federal and state net operating losses of approximately $5.0 billion and $2.5 billion, respectively. As of December 31, 2022, the Company had U.S. federal and state net operating losses of approximately $5.6 billion and $2.8 billion, respectively. The U.S. federal net operating loss carryforwards will expire at various dates beginning in 2035 through 2037 if not utilized, with the exception of $4.2 billion which can be carried forward indefinitely. The state net operating loss carryforwards will expire at various dates beginning in 2025 through 2043 if not utilized. Additionally, as of December 31, 2023, the Company had federal and California research and development credits of approximately $290.1 million and $99.5 million, respectively. As of December 31, 2022, the Company had federal and California research and development credits of approximately $230.2 million and $91.4 million, respectively. The federal research and development credits will begin to expire in the years 2027 through 2043 if not utilized and the California research and development credits have no expiration date. Utilization of the net operating losses and research and development credit carryforwards may be subject to an annual limitation due to the ownership percentage change limitations provided by the Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of the net operating loss and research and development credit carryforwards before utilization. As of December 31, 2023, the Company had U.S. federal capital loss carryforwards of $324.0 million. As of December 31, 2022, the Company had U.S. federal capital loss carryforwards of $113.1 million. The capital loss carryforwards will expire beginning in 2027 if not utilized. As of December 31, 2023, the Company had foreign net operating losses, primarily in the U.K., of approximately $464.7 million. These net operating losses can be carried forward indefinitely. As of December 31, 2023, the Company had an immaterial amount of earnings from its wholly-owned foreign subsidiaries indefinitely reinvested outside the U.S. The Company does not intend to repatriate these earnings and, accordingly, the Company does not provide for U.S. income taxes and foreign withholding tax on these earnings. On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on the Company’s current analysis of the provisions, the Company does not believe this legislation will have a material impact on its consolidated financial statements. Uncertain Tax Positions A reconciliation of the gross unrecognized tax benefits consists of the following (in thousands): Years Ended December 31, 2023 2022 2021 Unrecognized tax benefit beginning of year $ 81,904 $ 65,070 $ 75,557 Increases in current year tax positions 14,346 5,733 19,638 Increases in prior year tax positions 15,766 11,497 967 Decreases in prior year tax positions — (36) (30,895) Decreases in prior year tax positions due to settlements — (360) (197) Decreases in prior year tax positions due to lapse of statute of limitations — — — Unrecognized tax benefit end of year $ 112,016 $ 81,904 $ 65,070 As of December 31, 2023, 2022, and 2021, the Company recorded gross unrecognized tax benefits of $112.0 million, $81.9 million, and $65.1 million, respectively, that, if recognized, would not benefit the Company’s effective tax rate due to the valuation allowance that currently offsets deferred tax assets. As of December 31, 2023, no significant increases or decreases are expected to the Company’s uncertain tax positions within the next twelve months. It is the Company’s policy to recognize interest and penalties related to income tax matters in provision for income taxes on the consolidated statements of operations. The Company has recorded immaterial interest and penalties related to uncertain tax positions as of December 31, 2023, 2022, and 2021. The Company files U.S. federal, state, and foreign income tax returns in jurisdictions with varying statutes of limitation. The material jurisdictions where the Company is subject to potential examination by tax authorities are the U.S. (federal and state) for tax years 2004 through 2023 and the U.K. for tax years 2017 through 2023. |
Net Earnings (Loss) Per Share A
Net Earnings (Loss) Per Share Attributable to Common Stockholders | 12 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Net Earnings (Loss) Per Share Attributable to Common Stockholders | Net Earnings (Loss) Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share amounts): As of December 31, 2023 2022 2021 Numerator Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share $ 209,825 $ (373,705) $ (520,379) Denominator Weighted-average shares used in computing net earnings (loss) per share: Basic 2,147,446 2,063,793 1,923,617 Effect of dilutive shares 150,481 — — Diluted 2,297,927 2,063,793 1,923,617 Net earnings (loss) per share Net earnings (loss) per share attributable to common stockholders: Basic $ 0.10 $ (0.18) $ (0.27) Diluted $ 0.09 $ (0.18) $ (0.27) The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net earnings (loss) per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): As of December 31, 2023 2022 2021 Options and SARs issued and outstanding 162,000 326,913 349,977 RSUs and P-RSUs outstanding 13,245 126,426 153,749 Warrants to purchase common stock — 13,042 13,042 Total 175,245 466,381 516,768 |
Segment and Geographic Informat
Segment and Geographic Information | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Segment and Geographic Information | Segment and Geographic Information The following reporting segment tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the CODM evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented. Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. A segment’s contribution is calculated as segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level, or are noncash costs. These unallocated and noncash costs include stock-based compensation expense, research and development expenses, and general and administrative expenses. Financial information for each reportable segment was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Revenue: Government $ 1,222,215 $ 1,071,776 $ 897,356 Commercial 1,002,797 834,095 644,533 Total revenue $ 2,225,012 $ 1,905,871 $ 1,541,889 Years Ended December 31, 2023 2022 2021 Amount % Amount % Amount % Contribution: Government $ 724,970 59 % $ 620,677 58 % $ 541,883 60 % Commercial 520,585 52 % 414,496 50 % 357,546 55 % Total contribution $ 1,245,555 56 % $ 1,035,173 54 % $ 899,429 58 % The reconciliation of contribution to income (loss) from operations is as follows (in thousands): Years Ended December 31, 2023 2022 2021 Income (loss) from operations $ 119,966 $ (161,201) $ (411,046) Research and development expenses (1) 306,560 265,808 237,189 General and administrative expenses (1) 343,126 365,768 295,071 Total stock-based compensation expense 475,903 564,798 778,215 Total contribution $ 1,245,555 $ 1,035,173 $ 899,429 ————— (1) Excludes stock-based compensation expense. Geographic Information Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Years Ended December 31, 2023 2022 2021 Amount % Amount % Amount % Revenue: United States $ 1,378,247 62 % $ 1,161,416 61 % $ 879,156 57 % United Kingdom 235,257 11 % 220,942 12 % 173,362 11 % Rest of world (1) 611,508 27 % 523,513 27 % 489,371 32 % Total revenue $ 2,225,012 100 % $ 1,905,871 100 % $ 1,541,889 100 % ————— (1) No other country represented 10% or more of total revenue for the years ended December 31, 2023 , 2022, or 2021 . Property and equipment, net is attributed to the Company’s office locations as follows (in thousands, except percentages): As of December 31, 2023 2022 Amount % Amount % Property and equipment, net: United States $ 28,825 60 % $ 46,599 67 % Japan 11,440 24 % 13,318 19 % United Kingdom 5,851 12 % 6,746 10 % Rest of world 1,642 4 % 2,507 4 % Total property and equipment, net $ 47,758 100 % $ 69,170 100 % |
Business Combinations
Business Combinations | 12 Months Ended |
Dec. 31, 2023 | |
Business Combination and Asset Acquisition [Abstract] | |
Business Combinations | Business Combinations On November 8, 2022, the Company gained the right to majority representation on the board of directors of Palantir Japan, thereby obtaining a controlling interest. Prior to obtaining a controlling interest, the Company accounted for its 50% ownership in Palantir Japan as an equity method investment, which was created to distribute Palantir platforms to the Japanese market. This transaction was accounted for as a “step acquisition” (as defined by U.S. GAAP), as such, the Company remeasured its pre-existing equity interest in Palantir Japan immediately prior to the completion of the acquisition to its estimated fair value. The results of Palantir Japan have been included in the Company’s consolidated financial statements since the acquisition date, with the portion outside of its control forming a noncontrolling interest. The fair value of Palantir Japan on the acquisition date totaled $149.0 million, which included the Company’s equity interest immediately prior to the acquisition of $74.5 million and the noncontrolling interest of $74.5 million. The amounts recognized of assets acquired and liabilities assumed as of the acquisition date included: cash of $66.7 million; goodwill of $36.1 million; intangible assets of $34.7 million related to customer relationships, reacquired rights, and backlog; $32.5 million of other identifiable assets; and $21.0 million of net liabilities. The intangible assets are reported in other assets and are being amortized over a period of two |
Intangible Assets
Intangible Assets | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets | Intangible Assets Intangible assets subject to amortization that are not fully amortized are as follows (in thousands): Weighted average useful life As of December 31, 2023 As of December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Customer relationships 3.83 $ 10,400 $ (2,427) $ 7,973 $ 10,400 $ (347) $ 10,053 Reacquired rights 5.83 17,618 (2,936) 14,682 17,619 (420) 17,199 Backlog 0.83 6,700 (3,908) 2,792 6,700 (558) 6,142 Other 0.27 4,225 (3,770) 455 5,717 (3,572) 2,145 Total intangible assets $ 38,943 $ (13,041) $ 25,902 $ 40,436 $ (4,897) $ 35,539 Amortization expense of intangible assets was $9.6 million and not material for the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows (in thousands): Year ended December 31, Amount 2024 $ 7,844 2025 4,597 2026 4,597 2027 4,250 2028 2,517 Thereafter 2,097 Total $ 25,902 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Pay vs Performance Disclosure | |||
Net Income (Loss) | $ 209,825 | $ (373,705) | $ (520,379) |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended | 12 Months Ended |
Dec. 31, 2023 shares | Dec. 31, 2023 shares | |
Trading Arrangements, by Individual | ||
Non-Rule 10b5-1 Arrangement Adopted | false | |
Rule 10b5-1 Arrangement Terminated | false | |
Non-Rule 10b5-1 Arrangement Terminated | false | |
Alexander Moore [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On November 30, 2023, Alexander Moore, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 257,499 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until February 28, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement. | |
Name | Alexander Moore | |
Title | member of our Board of Directors | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | November 30, 2023 | |
Arrangement Duration | 456 days | |
Aggregate Available | 257,499 | 257,499 |
Eric Woersching [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On December 8, 2023, Eric Woersching, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 35,026 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until June 6, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement. | |
Name | Eric Woersching | |
Title | member of our Board of Directors | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | December 8, 2023 | |
Arrangement Duration | 546 days | |
Aggregate Available | 35,026 | 35,026 |
David Glazer [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On December 12, 2023, David Glazer, our Chief Financial Officer and Treasurer, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 1,479,169 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until September 11, 2024, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement. | |
Name | David Glazer | |
Title | Chief Financial Officer and Treasurer | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | December 12, 2023 | |
Arrangement Duration | 274 days | |
Aggregate Available | 1,479,169 | 1,479,169 |
Alexander Karp [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On December 12, 2023, Alexander Karp, our Chief Executive Officer and a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the potential sales of shares of our Class A common stock through various transactions upon the occurrence and satisfaction of certain price and/or other conditions, with 48,900,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions, less any shares to be withheld and/or sold to satisfy applicable tax withholdings. The trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). The duration of the trading arrangement is until June 1, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement. | |
Name | Alexander Karp | |
Title | Chief Executive Officer and a member of our Board of Directors | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | December 12, 2023 | |
Arrangement Duration | 537 days | |
Aggregate Available | 48,900,000 | 48,900,000 |
Rivendell 7 LLC Plan [Member] | Peter Thiel [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On December 12, 2023, Rivendell 7 LLC, a stockholder whose shares may be deemed to be beneficially owned by Peter Thiel (the Chairman of our Board of Directors), adopted a Rule 10b5-1 arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), subject to the satisfaction of certain price and/or other conditions, with 15,000,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. The duration of the trading arrangement is until March 12, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement. | |
Name | Peter Thiel | |
Title | Chairman of our Board of Directors | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | December 12, 2023 | |
Arrangement Duration | 456 days | |
Aggregate Available | 15,000,000 | 15,000,000 |
STS Holdings II LLC Plan [Member] | Peter Thiel [Member] | ||
Trading Arrangements, by Individual | ||
Material Terms of Trading Arrangement | On December 12, 2023, STS Holdings II LLC, a stockholder whose shares may be deemed to be beneficially owned by Peter Thiel (the Chairman of our Board of Directors), adopted a Rule 10b5-1 arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), subject to the satisfaction of certain price and/or other conditions, with 5,000,000 shares being the total of the maximum number of all shares subject to any condition when summed across all possible conditions. Trading under the arrangement is not authorized to begin until after all trades under the trading arrangement entered into by Rivendell 7 LLC described above are completed or expired without execution. The duration of the trading arrangement is until March 12, 2025, or earlier, upon the completion or expiration of all transactions subject to the trading arrangement. | |
Name | Peter Thiel | |
Title | Chairman of our Board of Directors | |
Rule 10b5-1 Arrangement Adopted | true | |
Adoption Date | December 12, 2023 | |
Arrangement Duration | 456 days | |
Aggregate Available | 5,000,000 | 5,000,000 |
Significant Accounting Polici_2
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Consolidation | Basis of Presentation and Consolidation The accompanying consolidated financial statements have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission regarding annual financial reporting. The accompanying consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over, but does not control, the investee are accounted for using the equity method of accounting. Certain prior year balances have been reclassified to conform to the current year presentation. Such reclassifications did not affect total revenues, income (loss) from operations, net income (loss), or cash flows. The Company’s fiscal year ends on December 31. |
Use of Estimates | Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying consolidated financial statements include, but are not limited to, the identification of performance obligations in customer contracts, the valuation of deferred tax assets and uncertain tax positions, and the collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. |
Segments | Segments The Company has two operating segments, commercial and government, which were determined based on the manner in which the chief operating decision maker (“CODM”), who is the Chief Executive Officer, manages the operations of the Company for purposes of allocating resources and evaluating performance. Various factors, including the Company’s organizational and management reporting structure and customer type, were considered in determining these operating segments. The Company’s operating segments are described below: • Commercial: This segment primarily serves customers working in non-government industries. • Government: This segment primarily serves customers that are United States (“U.S.”) government and non-U.S. government agencies. |
Cash, Cash Equivalents, and Restricted Cash | Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents primarily consist of amounts invested in money market funds and available-for-sale debt securities. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands): As of December 31, 2023 2022 2021 Cash and cash equivalents $ 831,047 $ 2,598,540 $ 2,290,674 Restricted cash included in prepaid expenses and other current assets 370 16,244 36,628 Restricted cash included in other assets 18,690 12,551 39,612 Total cash, cash equivalents, and restricted cash $ 850,107 $ 2,627,335 $ 2,366,914 |
Accounts Receivable and Allowance for Credit Losses | Accounts Receivable and Allowance for Credit Losses Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The Company generally grants non-collateralized credit terms to its customers. Allowance for credit losses is based on the Company’s best estimate of probable losses inherent in its accounts receivable portfolio and is determined based on expectations of the customer’s ability to pay by considering factors such as customer type (commercial or government), historical experience, financial position of the customer, age of the accounts receivable, current economic conditions, and reasonable and supportable forward-looking factors about its portfolio and future economic conditions. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success. Based upon the Company’s assessment as of December 31, 2023 and 2022, the Company recorded an allowance for credit losses of $10.5 million and $10.1 million, respectively. |
Debt Securities | Debt Securities Debt securities are primarily comprised of U.S. treasury securities. The debt securities are classified as available-for-sale at the time of purchase and are reevaluated as of each balance sheet date. The Company considers the majority of its available-for-sale debt securities as available for use in current operations and may sell these securities at any time, and therefore classifies these securities as current assets in its consolidated balance sheets. Debt securities included in marketable securities on the consolidated balance sheets consist of U.S. treasury securities with original maturities of greater than three months at the time of purchase, and the remaining U.S. treasury securities are included in cash and cash equivalents. Interest income on debt securities is included in other income (expense), net on the consolidated statements of operations. The majority of the Company’s available-for-sale securities are recorded at fair value each reporting period using quoted prices of similar instruments and are classified within Level 2 of the fair value hierarchy. The Company evaluates investments with unrealized loss positions for other than temporary impairment by assessing if they are related to deterioration in credit risk and whether it expects to recover the entire amortized cost basis of the security, the Company’s intent to sell, and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their cost basis. Credit-related impairment losses, not to exceed the amount that fair value is less than the amortized cost basis, are recognized in other income (expense), net in the consolidated statements of operations. Unrealized gains and non-credit related losses are reported as a separate component of accumulated other comprehensive loss, net in the consolidated balance sheets until realized. Realized gains and losses and declines in value judged to be other than temporary are determined based on the specific identification method and are reported in other income (expense), net in the consolidated statements of operations. |
Concentrations of Credit Risk | Concentrations of Credit Risk Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, accounts receivable, marketable securities, and privately-held equity securities. Cash equivalents primarily consist of money market funds and U.S. treasury securities with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented in the consolidated balance sheets. The Company’s accounts receivable balances as of December 31, 2023 and 2022 were $364.8 million and $258.3 million, respectively. Customer I represented 15% of total accounts receivable as of December 31, 2023, and no other customer represented more than 10% of total accounts receivable as of December 31, 2023. No customer represented more than 10% of total accounts receivable as of December 31, 2022. For the years ended December 31, 2023, 2022, and 2021, no customer represented 10% or more of total revenue. |
Alternative Investments | Alternative Investments Alternative investments include gold bars and are recorded in prepaid expenses and other current assets on the consolidated balance sheets. The investments are initially recorded at cost and subsequently remeasured at the lower of cost or market each reporting period. Market value is determined by using quoted market prices of identical or similar assets from active markets. Unrealized losses are recorded in other income (expense), net in the consolidated statements of operations. Realized gains and losses are recorded in other income (expense), net upon realization. |
Property and Equipment, Net | Property and Equipment, Net Property and equipment, net are stated at cost less accumulated depreciation and amortization. Depreciation is recognized using the straight-line method over the estimated useful lives of the respective assets, which are generally three years. Leasehold improvements are capitalized and amortized using the straight-line method over the shorter of the remaining lease term or the estimated useful life, which is generally five years. Maintenance and repairs that do not improve or extend the useful lives of the assets are expensed when incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation and amortization are derecognized from the consolidated balance sheets and any resulting gain or loss is recorded in the consolidated statements of operations in the period realized. |
Privately-held Equity Securities | Privately-held Equity Securities Equity securities in privately-held companies without readily determinable fair values are recorded using the measurement alternative. Such investments are carried at cost, less any impairments, and are adjusted for subsequent observable price changes in orderly transactions for identical or similar investments of the same issuer. Changes in the basis of the equity securities are recognized in other income (expense), net in the consolidated statements of operations. |
Business Combinations | Business Combinations Business combinations are accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) 805, Business Combinations, and are included in our consolidated financial statements from their respective acquisition dates. Assets acquired and liabilities assumed, if any, are measured at fair value on the acquisition date using the appropriate valuation method. Goodwill generated from acquisitions is recognized if the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests is in excess of the net fair value of the identifiable assets acquired and the liabilities assumed. In determining the fair value of identifiable assets, we use various valuation techniques which require us to make estimates and assumptions surrounding projected revenues and costs, future growth, and discount rates. |
Goodwill | Goodwill Goodwill represents the excess of the fair value of the purchase consideration transferred, or the fair value of the acquirer’s interest in the acquiree if no consideration is transferred, and any noncontrolling interests over the net fair value of the identifiable assets acquired and the liabilities assumed in business combinations. Goodwill is not amortized but is subject to an annual impairment test. We perform our annual goodwill impairment assessment on the first day of the fourth quarter. Tests are performed more frequently if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Goodwill is recorded in other assets in the consolidated balance sheet. |
Other Intangible Assets | Other Intangible Assets |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparing the carrying amount of an asset to the future undiscounted cash flows that the asset is expected to generate. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. Impairments of long-lived assets during the years ended December 31, 2023, 2022, and 2021 were not material. |
Leases | Leases The Company determines if an arrangement is a lease at inception. An arrangement is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange for consideration. If a lease is identified, classification is determined at lease commencement. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The Company’s leases do not provide an implicit interest rate and therefore the Company estimates its incremental borrowing rate to discount lease payments. The incremental borrowing rate reflects the interest rate that the Company would have to pay to borrow on a collateralized basis an amount equal to the lease payments in a similar economic environment over a similar term. Operating lease right-of-use (“ROU”) assets are based on the corresponding lease liability adjusted for any lease payments made at or before commencement, initial direct costs, and lease incentives. Renewals or early terminations are not accounted for unless the Company is reasonably certain to exercise these options. Operating lease expense is recognized and the ROU asset is amortized on a straight-line basis over the lease term. The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component. For short-term leases, defined as leases with a term of twelve months or less, the Company elected the practical expedient to not recognize an associated lease liability and ROU asset. Lease payments for short-term leases are expensed on a straight-line basis over the lease term. Operating leases are included in operating lease right-of-use assets, operating lease liabilities, and operating lease liabilities, non-current |
Fair Value Measurement | Fair Value Measurement Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability, or an exit price, in the principal or most advantageous market for that asset or liability in an orderly transaction between market participants on the measurement date. The Company measures fair value based on a three-level hierarchy of inputs, maximizing the use of observable inputs, where available, and minimizing the use of unobservable inputs when measuring fair value. A financial instrument’s level within the three-level hierarchy is based on the lowest level of input that is significant to the fair value measurement. The three-level hierarchy of inputs is as follows: Level 1: Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; Level 2: Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on the Company’s own assumptions about current market conditions and require significant management judgment or estimation. Financial instruments consist of money market funds and certificates of deposit included in cash equivalents and restricted cash, accounts receivable, marketable securities, other assets accounted for at fair value, accounts payable, and accrued liabilities. Money market funds, certificates of deposit, and marketable securities are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. |
Revenue Recognition | Revenue Recognition The Company generates revenue from the sale of subscriptions to access its software platforms in the Company’s hosted environment, along with ongoing operations and maintenance (“O&M”) services (“Palantir Cloud”); software licenses, primarily term licenses in the customers’ environments, with ongoing O&M services (“On-Premises Software”); and professional services. In accordance with ASC 606, Revenue from Contracts with Customers , the Company recognizes revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for promised goods or services. The Company applies the following five-step revenue recognition model in accounting for its revenue arrangements: • Identification of the contract(s) with the customer, including whether collectability of the consideration is probable by considering the customers’ ability and intention to pay; • Identification of the performance obligations in the contract; • Determination of the transaction price; • Allocation of the transaction price to the performance obligations in the contract; and • Recognition of revenue when, or as, the Company satisfies a performance obligation. Additionally, the pricing of the Company’s contracts is generally fixed; however, it is possible for contracts to include variable consideration, which can be based on subjective or objective criteria. The Company includes the estimated amount of variable consideration that it expects to receive to the extent it is probable that a significant revenue reversal will not occur. Each of the Company’s significant performance obligations and the Company’s application of ASC 606 to its revenue arrangements is discussed in further detail below. Palantir Cloud The Company’s Palantir Cloud subscriptions grant customers the right to access the software functionality in a hosted environment controlled by Palantir and are sold together with stand-ready O&M services, as further described below. The Company agrees to provide continuous access to its hosted software platforms throughout the contract term. Revenue associated with Palantir Cloud subscriptions is generally recognized over the contract term on a ratable basis, which is consistent with the transfer of control of the Palantir Cloud subscription to the customer. On-Premises Software Sales of the Company’s software licenses, primarily term licenses, grant customers the right to use functional intellectual property, either on their internal hardware infrastructure or on their own cloud instance, over the contractual term and are also sold together with stand-ready O&M services. The O&M services include critical updates, support, and maintenance services required to operate the software and, as such, are necessary for the software to maintain its intended utility over the contractual term. Because of this requirement, the Company has concluded that the software licenses and O&M services, which together the Company refers to as On-Premises Software, are highly interdependent and interrelated and represent a single distinct performance obligation within the context of the contract. Revenue is generally recognized over the contract term on a ratable basis. Professional Services The Company’s professional services support the customers’ use of the software platforms and include, as needed, on-demand user support, user-interface configuration, training, and ongoing ontology and data modeling support. Professional services contracts typically include the provision of on-demand professional services for the duration of the contractual term. These services are typically coterminous with a Palantir Cloud subscription or the On-Premises Software. Professional services are on-demand, whereby the Company performs services throughout the contract period; therefore, the revenue is recognized over the contractual term. Contract Liabilities The timing of customer billings and payments relative to the start of the service period varies from contract to contract; however, the Company bills many of its customers in advance of the provision of services under its contracts, resulting in contract liabilities consisting of either deferred revenue or customer deposits (“contract liabilities”). Deferred revenue represents billings under noncancelable contracts before the related product or service is transferred to the customer. Customer deposits consist of amounts billed and/or paid in advance of the start of the contractual term or for anticipated revenue generating activities for the portion of a contract term that is subject to cancellation by its customers. Many of the Company’s arrangements include terms that allow the customer to terminate the contract for convenience and receive a pro-rata refund of the amount of the customer deposit for the period of time remaining in the contract term after the applicable termination notice period expires. In these arrangements, the Company concluded there are no enforceable rights and obligations after such notice period and therefore the consideration received or due from the customer that is subject to termination for convenience is recorded as customer deposits. The payment terms and conditions vary by contract; however, the Company’s terms generally require payment within 30 to 60 days from the invoice date. In instances where the timing of revenue recognition differs from the timing of payment, the Company elected to apply the practical expedient in accordance with ASC 606 to not adjust contract consideration for the effects of a significant financing component as the Company expects, at contract inception, that the period between when promised goods and services are transferred to the customer and when the customer pays for those goods and services will be one year or less. As such, the Company determined its contracts do not generally contain a significant financing component. Areas of Judgment and Estimation The Company’s contracts with customers can include multiple promises to transfer goods or services to the customer. Determining whether promises are distinct performance obligations that should be accounted for separately – or not distinct within the context of the contract and, thus, accounted for together – requires significant judgment. The Company concluded that the promise to provide a software license is highly interdependent and interrelated with the promise to provide O&M services and such promises are not distinct within the context of its contracts and are accounted for as a single performance obligation as the Company’s On-Premises Software. Significant estimates and assumptions are used in the identification of performance obligations in customer contracts and collectability of contract consideration, including accounts receivable. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect our financial position and results of operations. Costs to Obtain and Fulfill Contracts Incremental costs of obtaining a contract include only those costs that are directly related to the acquisition of contracts, including sales commissions, and that would not have been incurred if the contract had not been obtained. The Company recognizes a contract cost asset for the incremental costs of obtaining a contract with a customer if it is expected that the economic benefit and amortization period will be longer than one year. Costs to obtain contracts were not material in the periods presented. The Company recognizes an asset for the costs to fulfill a contract with a customer if the costs are specifically identifiable, generate or enhance resources used to satisfy future performance obligations, and are expected to be recovered. Costs to fulfill contracts were not material in the periods presented. |
Software Development Costs | Software Development Costs The Company evaluates capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based on the Company’s product development process and substantial development risks, technological feasibility is generally established for the Company’s products when they are made available for general release. Accordingly, most costs are charged to research and development expense in the period incurred. |
Cost of Revenue | Cost of Revenue |
Sales and Marketing Costs | Sales and Marketing Costs Sales and marketing costs primarily include salaries, stock-based compensation expense, commissions, and benefits for the sales force and personnel involved in sales functions, executing on pilots, including bootcamps, and performing other brand building and customer growth activities, as well as third-party cloud hosting services for pilots, marketing and sales event-related costs, travel costs, and allocated overhead. The Company generally charges all such costs to sales and marketing expense in the period incurred. Advertising costs are expensed as incurred and included in sales and marketing expense within the consolidated statements of operations. Advertising expense totaled $21.4 million, $38.6 million, and $26.3 million for the years ended December 31, 2023, 2022, and 2021, respectively. |
Research and Development Costs | Research and Development Costs |
Commitments and Contingencies | Commitments and Contingencies |
Stock-Based Compensation | Stock-Based Compensation The Company accounts for stock-based compensation expense in accordance with the fair value recognition and measurement provisions of GAAP, which require compensation cost for the grant-date fair value of stock-based awards to be recognized over the requisite service period. The Company determines the fair value of stock-based awards granted or modified on the grant date or modification date using appropriate valuation techniques. The Company recognizes forfeitures as they occur. Service-Based Vesting The Company grants RSUs and stock option awards that vest based upon the satisfaction of only a service condition. For RSUs, the Company determines the grant-date fair value of the RSUs as the fair value of the Company’s common stock on the grant date. The Company records stock-based compensation expense for stock options and RSUs that vest based upon the satisfaction of only a service condition on a straight-line basis over the requisite service period, which is generally one Performance-Based Vesting The Company also grants awards, including RSUs, that vest upon the satisfaction of both a service condition and a performance condition. The Company determines the grant-date fair value of RSUs with both a service-based vesting condition and a performance-based vesting condition as the fair value of the Company’s common stock on the grant date and records stock-based compensation expense using the accelerated attribution method over the service period. The performance-based vesting condition for the RSUs granted prior to September 30, 2020, the date the Company completed a direct listing of its Class A common stock on the New York Stock Exchange (the “Direct Listing”) was satisfied upon the occurrence of the Company’s Direct Listing. For performance-based RSUs granted after the Direct Listing (“P-RSUs”), the Company recognizes expense from the number of P-RSUs expected to vest, determined based on the level of achievement against certain performance conditions, over the requisite service period when it is probable that the performance condition will be achieved. The probability of achievement is assessed periodically to determine whether the performance metric continues to be probable. When there is a change in the assessment of the probability of achievement, any cumulative effect of the change is recognized in the period of the change and any remaining expense of the related awards is amortized over the remaining service period. |
Employee Benefit Plan | Employee Benefit Plan The Company sponsors a 401(k) tax-deferred savings plan for all employees who meet certain eligibility requirements. Participants may contribute, on a pretax and post-tax basis, a percentage of their qualifying annual compensation, but not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company may make additional matching contributions on behalf of the participants. The Company did not make matching contributions for the years ended December 31, 2023, 2022, and 2021. |
Income Taxes | Income Taxes The Company estimates its current tax expense together with assessing temporary differences resulting from differing treatment of items not currently deductible for tax purposes. These differences result in deferred tax assets and liabilities on the Company’s consolidated balance sheets, which are estimated based upon the difference between the financial statement and tax bases of assets and liabilities using the enacted tax rates that will be in effect when these differences reverse. In general, deferred tax assets represent future tax benefits to be received when certain expenses previously recognized in the Company’s consolidated statements of operations become deductible expenses under applicable income tax laws or loss or credit carryforwards are utilized. Accordingly, the realization of the Company’s deferred tax assets is dependent on future taxable income against which these deductions, losses, and credits can be utilized. The Company evaluates the realizability of its deferred tax assets and recognizes a valuation allowance when it is more likely than not that a future benefit on such deferred tax assets will not be realized. The Company considers all evidence, both positive and negative, in determining any required valuation allowance and evaluates the need for a valuation allowance on a regular basis. The Company performs an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. Such assessment is required on a jurisdiction by jurisdiction basis. The Company reviews the recognition of deferred tax assets on a regular basis to determine if realization of such assets is more likely than not. A valuation allowance is provided when it is more likely than not that such assets will not be realized. If certain factors change and the Company determines that the deferred tax assets are realizable at a more-likely-than not level, it will adjust the valuation allowance in the period the determination is made. Changes in the valuation allowance, when recorded, would be included in the Company’s consolidated statements of operations. Management’s judgment is required in determining the Company’s valuation allowance recorded against its net deferred tax assets. The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement. The Company recognizes interest and penalties related to uncertain tax positions in its provision for income taxes. The Company is subject to the Global Intangible Low Taxed Income (“GILTI”) tax in the U.S. and has elected to treat taxes on future GILTI inclusions as current period expense if and when incurred. |
Net Earnings (Loss) Per Share Attributable to Common Stockholders | Net Earnings (Loss) Per Share Attributable to Common Stockholders The Company computes net earnings (loss) per share attributable to its common stockholders using the two-class method required for participating securities, which determines net earnings (loss) per common share for each class of common stock and participating securities according to dividends declared or accumulated and participation rights in distributed and undistributed earnings. The two-class method requires income available to common stockholders for the period to be allocated between common stock and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. The rights, including the liquidation and dividend rights, of the holders of Class A, Class B, and Class F common stock (collectively, the “common stock”) are identical, except with respect to voting and conversion. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting net earnings (loss) per share will, therefore, be the same for all classes of common stock on an individual or comb ined basis. As such, the Company has presented the net income (loss) attributed to its common stock on a combined basis. |
Noncontrolling Interests | Noncontrolling Interests A noncontrolling interest represents the proportionate equity interest in a subsidiary that is not attributable, either directly or indirectly, to the Company and is reported as equity of the Company, separate from the Company’s controlling interest. Revenues, expenses, gains, losses, net income (loss), and other comprehensive income (loss) are reported in the consolidated financial statements at the consolidated amounts, which include the amounts attributable to both the controlling and noncontrolling interest. |
Foreign Currency | Foreign Currency Generally, the functional currency of the Company’s international subsidiaries is the local currency of the country in which they operate. The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each reporting period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recognized as a cumulative translation adjustment and included in accumulated other comprehensive income (loss). For transactions that are not denominated in the local functional currency, the Company remeasures monetary assets and liabilities at exchange rates in effect at the end of each reporting period. Transaction gains and losses from the remeasurement are recognized in other income (expense), net within the consolidated statements of operations. |
Recent Accounting Pronouncements Not Yet Adopted | Recent Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. This standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company is currently evaluating the impacts of the new standard. In December 2023, the FASB issued ASU 2023-09, Income Taxes – Improvements to Income Tax Disclosures , requiring enhancements and further transparency to certain income tax disclosures, most notably the tax rate reconciliation and income taxes paid. This ASU is effective for fiscal years beginning after December 15, 2024 on a prospective basis and retrospective application is permitted. The Company is currently evaluating the impacts of the new standard. |
Significant Accounting Polici_3
Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Schedule of Cash and Cash Equivalents | The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the amounts shown in the consolidated statements of cash flows (in thousands): As of December 31, 2023 2022 2021 Cash and cash equivalents $ 831,047 $ 2,598,540 $ 2,290,674 Restricted cash included in prepaid expenses and other current assets 370 16,244 36,628 Restricted cash included in other assets 18,690 12,551 39,612 Total cash, cash equivalents, and restricted cash $ 850,107 $ 2,627,335 $ 2,366,914 |
Investments and Fair Value Me_2
Investments and Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Summary Of Assets and Liabilities that are Measured at Fair Value on a Recurring and Nonrecurring Basis | The following tables present the Company’s assets that are measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation (in thousands): As of December 31, 2023 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 576,565 $ 576,565 $ — $ — U.S. treasury securities 10,079 — 10,079 — Certificates of deposit 938 — 938 — Prepaid expenses and other current assets and other assets: Certificates of deposit 4,777 — 4,777 — Marketable securities: U.S. treasury securities 2,824,861 — 2,824,861 — Publicly-traded equity securities 18,271 18,271 — — Total $ 3,435,491 $ 594,836 $ 2,840,655 $ — As of December 31, 2022 Total Level 1 Level 2 Level 3 Assets: Cash and cash equivalents: Money market funds $ 1,149,302 $ 1,149,302 $ — $ — Certificates of deposit 6,791 — 6,791 — Prepaid expenses and other current assets and other assets: Certificates of deposit 18,707 — 18,707 — Marketable securities: Publicly-traded equity securities 35,135 35,135 — — Total $ 1,209,935 $ 1,184,437 $ 25,498 $ — |
Debt Securities, Available-for-Sale | As of December 31, 2023, available-for-sale debt securities consisted of the following (in thousands): As of December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 2,831,505 $ 4,520 $ (1,085) $ 2,834,940 Total debt securities $ 2,831,505 $ 4,520 $ (1,085) $ 2,834,940 Included in cash and cash equivalents $ 10,078 $ 1 $ — $ 10,079 Included in marketable securities $ 2,821,427 $ 4,519 $ (1,085) $ 2,824,861 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Balance Sheet Related Disclosures [Abstract] | |
Schedule of Property and Equipment, Net | Property and equipment, net consisted of the following (in thousands): As of December 31, 2023 2022 Leasehold improvements $ 83,139 $ 80,378 Computer equipment, software, and other 50,844 52,688 Furniture and fixtures 13,834 13,010 Construction in progress 2,099 5,506 Total property and equipment, gross 149,916 151,582 Less: accumulated depreciation and amortization (102,158) (82,412) Total property and equipment, net $ 47,758 $ 69,170 |
Schedule of Accrued Liabilities | Accrued liabilities consisted of the following (in thousands): As of December 31, 2023 2022 Accrued payroll and related expenses $ 83,094 $ 43,495 Accrued taxes 47,257 41,326 Accrued other liabilities 92,640 87,894 Total accrued liabilities $ 222,991 $ 172,715 |
Leases (Tables)
Leases (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Leases [Abstract] | |
Supplemental Balance Sheet Information Related To Lease Liabilities and Components of Lease Expense | Supplemental balance sheet information related to lease liabilities at December 31, 2023 and 2022 was as follows (in thousands): As of December 31, Lease-Related Assets and Liabilities Financial Statement Line Items 2023 2022 Right-of-use assets: Operating leases Operating lease right-of-use assets $ 182,863 $ 200,240 Total right-of-use assets $ 182,863 $ 200,240 Lease liabilities: Operating leases Operating lease liabilities $ 54,176 $ 45,099 Operating lease liabilities, noncurrent 175,216 204,305 Total lease liabilities $ 229,392 $ 249,404 The components of lease expense included in the Company's consolidated statements of operations include (in thousands): Years Ended December 31, 2023 2022 Operating lease expense $ 61,972 $ 55,483 Short-term lease expense 4,949 4,956 Variable lease expense 4,772 5,309 Sublease income (18,905) (13,011) Total lease expense, net $ 52,788 $ 52,737 The following table sets forth the supplemental information related to the Company's operating leases for the years ended December 31, 2023 and 2022 (in thousands): Years Ended December 31, 2023 2022 Cash paid for operating lease liabilities $ 63,374 $ 53,772 Lease liabilities arising from obtaining right-of-use assets $ 28,112 $ 28,169 |
Maturities of Operating Lease Liabilities | Maturities of operating lease liabilities as of December 31, 2023 were as follows (in thousands): As of December 31, 2023 Operating Lease Commitments Less: Sublease Income Net Lease Commitments Year ended December 31, 2024 $ 67,420 $ 16,593 $ 50,827 2025 57,053 14,357 42,696 2026 40,068 13,748 26,320 2027 28,278 14,423 13,855 2028 21,816 12,470 9,346 Thereafter 62,116 30,761 31,355 Total undiscounted liabilities 276,751 102,352 174,399 Less: Imputed interest (47,359) — (47,359) Total operating lease liabilities $ 229,392 $ 102,352 $ 127,040 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Summary of Total Authorized, Issued, And Outstanding Shares | The following represented the total authorized, issued, and outstanding shares for each class of common stock (in thousands): As of December 31, 2023 As of December 31, 2022 Authorized Issued and Outstanding Authorized Issued and Outstanding Class A Common Stock 20,000,000 2,096,982 20,000,000 1,995,414 Class B Common Stock 2,700,000 102,141 2,700,000 102,656 Class F Common Stock 1,005 1,005 1,005 1,005 Total 22,701,005 2,200,128 22,701,005 2,099,075 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Summary of Stock Option Activity | The following table summarizes stock option activity for the year ended December 31, 2023 (in thousands, except per share amounts): Options Outstanding Weighted-Average Exercise Price Per Share Weighted-Average Aggregate Intrinsic Value Balance as of December 31, 2022 326,913 $ 8.05 8.33 $ 272,603 Options exercised (46,079) 4.74 Options canceled and forfeited (2,364) 5.39 Balance as of December 31, 2023 278,470 $ 8.62 7.64 $ 2,381,172 Options vested and exercisable as of December 31, 2023 160,877 $ 6.66 6.93 $ 1,691,404 |
Summary of RSU Activity | The following table summarizes the RSU and P-RSU activity for the year ended December 31, 2023 (in thousands, except per share amounts): RSUs P-RSUs Units Outstanding Weighted Average Grant Date Fair Value per Share Units Outstanding Weighted Average Grant Date Fair Value per Share Unvested and outstanding as of December 31, 2022 126,426 $ 10.07 — $ — Granted 19,484 11.77 1,976 15.39 Vested (54,974) 9.57 — — Canceled (8,674) 11.08 — — Unvested and outstanding as of December 31, 2023 82,262 $ 10.71 1,976 $ 15.39 |
Summary of Stock-Based Compensation Expense | Total stock-based compensation expense was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Cost of revenue $ 35,995 $ 44,061 $ 68,546 Sales and marketing 160,645 196,301 242,910 Research and development 98,064 93,871 150,298 General and administrative 181,199 230,565 316,461 Total stock-based compensation expense $ 475,903 $ 564,798 $ 778,215 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Summary of Loss Before Provision for (benefit from) Income Taxes | Income (loss) before provision for income taxes consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 United States $ 174,637 $ (402,834) $ (514,200) Foreign 62,454 41,807 25,706 Income (loss) before provision for income taxes $ 237,091 $ (361,027) $ (488,494) |
Summary of Provision for (benefit from) Income Taxes | Provision for income taxes consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 Current: Federal $ — $ — $ — State 2,333 765 (88) Foreign 22,189 9,476 (11,343) Total current provision 24,522 10,241 (11,431) Deferred: Federal — — (111) State — — — Foreign (4,806) (174) 43,427 Total deferred provision (4,806) (174) 43,316 Total provision for income taxes $ 19,716 $ 10,067 $ 31,885 |
Summary of Reconciliation of Effective Income Tax Rate | A reconciliation of the expected tax provision at the statutory federal income tax rate to the Company’s recorded tax provision consisted of the following (in thousands): Years Ended December 31, 2023 2022 2021 Expected tax (benefit) at U.S. federal statutory rate $ 49,789 $ (75,592) $ (102,584) State income taxes - net of federal benefit 2,309 766 (88) Foreign tax rate differential 859 832 870 Research and development tax credits (45,667) (34,546) (94,591) Stock-based compensation (79,128) 1,374 (817,839) Non-deductible officers’ compensation 34,479 40,629 428,682 Change in valuation allowance 35,070 49,833 616,572 Base Erosion Anti-Abuse Tax and related elections 14,700 25,200 — Taxes withheld at source 4,378 — — Non-deductible expenses 3,610 — — Other (683) 1,571 863 Total provision for income taxes $ 19,716 $ 10,067 $ 31,885 |
Summary of Significant Deferred Tax Assets and Liabilities | Significant deferred tax assets and liabilities consisted of the following (in thousands): As of December 31, 2023 2022 Net operating loss carryforwards $ 1,317,684 $ 1,436,957 Capitalized research and experimental expenses 214,848 70,839 Reserves and accruals 99,105 76,905 Tax credit carryforwards 277,060 226,565 Stock-based compensation 139,419 203,735 Lease liabilities 53,902 58,056 Depreciation and amortization 14,413 29,665 Capitalized facilitative expenses 28,906 — Gross deferred tax assets 2,145,337 2,102,722 Outside basis difference — (6,512) Acquisition related intangibles (8,428) (10,225) Right-of-use assets (42,721) (46,295) Total net deferred tax assets before valuation allowance 2,094,188 2,039,690 Valuation allowance (2,102,251) (2,051,655) Net deferred tax assets (liabilities) $ (8,063) $ (11,965) |
Summary of Reconciliation of the Gross Unrecognized Tax Benefits | A reconciliation of the gross unrecognized tax benefits consists of the following (in thousands): Years Ended December 31, 2023 2022 2021 Unrecognized tax benefit beginning of year $ 81,904 $ 65,070 $ 75,557 Increases in current year tax positions 14,346 5,733 19,638 Increases in prior year tax positions 15,766 11,497 967 Decreases in prior year tax positions — (36) (30,895) Decreases in prior year tax positions due to settlements — (360) (197) Decreases in prior year tax positions due to lapse of statute of limitations — — — Unrecognized tax benefit end of year $ 112,016 $ 81,904 $ 65,070 |
Net Earnings (Loss) Per Share_2
Net Earnings (Loss) Per Share Attributable to Common Stockholders (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Earnings Per Share [Abstract] | |
Summary of Calculation of Basic and Diluted Net Loss Per Share | The following table presents the calculation of basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share amounts): As of December 31, 2023 2022 2021 Numerator Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share $ 209,825 $ (373,705) $ (520,379) Denominator Weighted-average shares used in computing net earnings (loss) per share: Basic 2,147,446 2,063,793 1,923,617 Effect of dilutive shares 150,481 — — Diluted 2,297,927 2,063,793 1,923,617 Net earnings (loss) per share Net earnings (loss) per share attributable to common stockholders: Basic $ 0.10 $ (0.18) $ (0.27) Diluted $ 0.09 $ (0.18) $ (0.27) |
Summary of Antidilutive Securities | The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net earnings (loss) per share attributable to common stockholders for the periods presented due to their anti-dilutive effect (in thousands): As of December 31, 2023 2022 2021 Options and SARs issued and outstanding 162,000 326,913 349,977 RSUs and P-RSUs outstanding 13,245 126,426 153,749 Warrants to purchase common stock — 13,042 13,042 Total 175,245 466,381 516,768 |
Segment and Geographic Inform_2
Segment and Geographic Information (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Segment Reporting [Abstract] | |
Summary of Financial Information for Each Reportable Segment | Financial information for each reportable segment was as follows (in thousands): Years Ended December 31, 2023 2022 2021 Revenue: Government $ 1,222,215 $ 1,071,776 $ 897,356 Commercial 1,002,797 834,095 644,533 Total revenue $ 2,225,012 $ 1,905,871 $ 1,541,889 Years Ended December 31, 2023 2022 2021 Amount % Amount % Amount % Contribution: Government $ 724,970 59 % $ 620,677 58 % $ 541,883 60 % Commercial 520,585 52 % 414,496 50 % 357,546 55 % Total contribution $ 1,245,555 56 % $ 1,035,173 54 % $ 899,429 58 % |
Summary of Reconciliation of Segment Financial Information to Loss from Operations | The reconciliation of contribution to income (loss) from operations is as follows (in thousands): Years Ended December 31, 2023 2022 2021 Income (loss) from operations $ 119,966 $ (161,201) $ (411,046) Research and development expenses (1) 306,560 265,808 237,189 General and administrative expenses (1) 343,126 365,768 295,071 Total stock-based compensation expense 475,903 564,798 778,215 Total contribution $ 1,245,555 $ 1,035,173 $ 899,429 ————— (1) Excludes stock-based compensation expense. |
Summary of Revenue by Geography | Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Years Ended December 31, 2023 2022 2021 Amount % Amount % Amount % Revenue: United States $ 1,378,247 62 % $ 1,161,416 61 % $ 879,156 57 % United Kingdom 235,257 11 % 220,942 12 % 173,362 11 % Rest of world (1) 611,508 27 % 523,513 27 % 489,371 32 % Total revenue $ 2,225,012 100 % $ 1,905,871 100 % $ 1,541,889 100 % ————— (1) No other country represented 10% or more of total revenue for the years ended December 31, 2023 , 2022, or 2021 . |
Summary of Property and Equipment, Net by Geography | Property and equipment, net is attributed to the Company’s office locations as follows (in thousands, except percentages): As of December 31, 2023 2022 Amount % Amount % Property and equipment, net: United States $ 28,825 60 % $ 46,599 67 % Japan 11,440 24 % 13,318 19 % United Kingdom 5,851 12 % 6,746 10 % Rest of world 1,642 4 % 2,507 4 % Total property and equipment, net $ 47,758 100 % $ 69,170 100 % |
Intangible Assets (Tables)
Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Finite-Lived Intangible Assets | Intangible assets subject to amortization that are not fully amortized are as follows (in thousands): Weighted average useful life As of December 31, 2023 As of December 31, 2022 Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Customer relationships 3.83 $ 10,400 $ (2,427) $ 7,973 $ 10,400 $ (347) $ 10,053 Reacquired rights 5.83 17,618 (2,936) 14,682 17,619 (420) 17,199 Backlog 0.83 6,700 (3,908) 2,792 6,700 (558) 6,142 Other 0.27 4,225 (3,770) 455 5,717 (3,572) 2,145 Total intangible assets $ 38,943 $ (13,041) $ 25,902 $ 40,436 $ (4,897) $ 35,539 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | As of December 31, 2023, expected amortization expense for the unamortized finite-lived intangible assets for the next five years and thereafter is as follows (in thousands): Year ended December 31, Amount 2024 $ 7,844 2025 4,597 2026 4,597 2027 4,250 2028 2,517 Thereafter 2,097 Total $ 25,902 |
Significant Accounting Polici_4
Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 |
Cash and Cash Equivalents [Line Items] | ||||
Cash and cash equivalents | $ 831,047 | $ 2,598,540 | $ 2,290,674 | |
Total cash, cash equivalents, and restricted cash | 850,107 | 2,627,335 | 2,366,914 | $ 2,128,146 |
Prepaid Expenses and Other Current Assets | ||||
Cash and Cash Equivalents [Line Items] | ||||
Restricted cash | 370 | 16,244 | 36,628 | |
Other Current Assets | ||||
Cash and Cash Equivalents [Line Items] | ||||
Restricted cash | $ 18,690 | $ 12,551 | $ 39,612 |
Significant Accounting Polici_5
Significant Accounting Policies - Additional Information (Detail) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 USD ($) segment | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | |
Accounting Policies [Line Items] | |||
Number of operating segments | segment | 2 | ||
Allowance for credit losses | $ 10,500 | $ 10,100 | |
Accounts receivable, net | $ 364,784 | 258,346 | |
Useful lives (in years) | 3 years | ||
Advertising expense | $ 21,400 | $ 38,600 | $ 26,300 |
Minimum | |||
Accounting Policies [Line Items] | |||
Share based payment award vesting period | 4 years | ||
Maximum | |||
Accounting Policies [Line Items] | |||
Share based payment award vesting period | 1 year | ||
Leasehold improvements | |||
Accounting Policies [Line Items] | |||
Useful lives (in years) | 5 years | ||
Customer I | Accounts Receivable Benchmark | Customer Concentration Risk | |||
Accounting Policies [Line Items] | |||
Concentration risk (in percent) | 15% |
Contract Liabilities and Rema_2
Contract Liabilities and Remaining Performance Obligations - Additional information (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Contract with customer, liability | $ 486.3 | $ 339.2 |
Revenue recognized from contract liability balances | 329.4 | $ 384.3 |
Remaining performance obligation | $ 1,200 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation (as percent) | 52% | |
Expected timing of satisfaction (in months) | 12 months | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Remaining performance obligation (as percent) | 37% | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Minimum | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Expected timing of satisfaction (in months) | 13 months | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01 | Maximum | ||
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | ||
Expected timing of satisfaction (in months) | 36 months |
Investments and Fair Value Me_3
Investments and Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Marketable securities: | |||
Debt securities | $ 2,834,940,000 | $ 0 | |
Total | 3,435,491,000 | 1,209,935,000 | |
Revenues | 2,225,012,000 | 1,905,871,000 | $ 1,541,889,000 |
Level 1 | |||
Marketable securities: | |||
Total | 594,836,000 | 1,184,437,000 | |
Level 2 | |||
Marketable securities: | |||
Total | 2,840,655,000 | 25,498,000 | |
Level 3 | |||
Marketable securities: | |||
Total | 0 | 0 | |
U.S. treasury securities | |||
Marketable securities: | |||
Debt securities | 2,834,940,000 | ||
Cash and Cash Equivalents | Money market funds | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 576,565,000 | 1,149,302,000 | |
Cash and Cash Equivalents | Money market funds | Level 1 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 576,565,000 | 1,149,302,000 | |
Cash and Cash Equivalents | Money market funds | Level 2 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 0 | 0 | |
Cash and Cash Equivalents | Money market funds | Level 3 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 0 | 0 | |
Cash and Cash Equivalents | U.S. treasury securities | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 10,079,000 | ||
Marketable securities: | |||
Debt securities | 10,079,000 | ||
Cash and Cash Equivalents | U.S. treasury securities | Level 1 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 0 | ||
Cash and Cash Equivalents | U.S. treasury securities | Level 2 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 10,079,000 | ||
Cash and Cash Equivalents | U.S. treasury securities | Level 3 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 0 | ||
Cash and Cash Equivalents | Certificates of deposit | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 938,000 | 6,791,000 | |
Cash and Cash Equivalents | Certificates of deposit | Level 1 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 0 | 0 | |
Cash and Cash Equivalents | Certificates of deposit | Level 2 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 938,000 | 6,791,000 | |
Cash and Cash Equivalents | Certificates of deposit | Level 3 | |||
Cash and cash equivalents: | |||
Cash and cash equivalents | 0 | 0 | |
Prepaid Expenses and Other Current Assets and Other Assets | Certificates of deposit | |||
Prepaid expenses and other current assets and other assets: | |||
Certificates of deposit | 4,777,000 | 18,707,000 | |
Prepaid Expenses and Other Current Assets and Other Assets | Certificates of deposit | Level 1 | |||
Prepaid expenses and other current assets and other assets: | |||
Certificates of deposit | 0 | 0 | |
Prepaid Expenses and Other Current Assets and Other Assets | Certificates of deposit | Level 2 | |||
Prepaid expenses and other current assets and other assets: | |||
Certificates of deposit | 4,777,000 | 18,707,000 | |
Prepaid Expenses and Other Current Assets and Other Assets | Certificates of deposit | Level 3 | |||
Prepaid expenses and other current assets and other assets: | |||
Certificates of deposit | 0 | 0 | |
Marketable Securities | U.S. treasury securities | |||
Marketable securities: | |||
Debt securities | 2,824,861,000 | ||
Marketable Securities | U.S. treasury securities | Level 1 | |||
Marketable securities: | |||
Debt securities | 0 | ||
Marketable Securities | U.S. treasury securities | Level 2 | |||
Marketable securities: | |||
Debt securities | 2,824,861,000 | ||
Marketable Securities | U.S. treasury securities | Level 3 | |||
Marketable securities: | |||
Debt securities | 0 | ||
Marketable Securities | U.S. treasury securities | |||
Marketable securities: | |||
U.S. treasury securities | 18,271,000 | 35,135,000 | |
Marketable Securities | U.S. treasury securities | Level 1 | |||
Marketable securities: | |||
U.S. treasury securities | 18,271,000 | 35,135,000 | |
Marketable Securities | U.S. treasury securities | Level 2 | |||
Marketable securities: | |||
U.S. treasury securities | 0 | 0 | |
Marketable Securities | U.S. treasury securities | Level 3 | |||
Marketable securities: | |||
U.S. treasury securities | $ 0 | $ 0 |
Investments and Fair Value Me_4
Investments and Fair Value Measurements - Available-For-Sale Debt Securities (Details) - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Debt Securities, Available-for-Sale [Line Items] | ||
Amortized Cost | $ 2,831,505,000 | |
Unrealized Gains | 4,520,000 | |
Unrealized Losses | (1,085,000) | |
Fair Value | 2,834,940,000 | $ 0 |
U.S. treasury securities | ||
Debt Securities, Available-for-Sale [Line Items] | ||
Amortized Cost | 2,831,505,000 | |
Unrealized Gains | 4,520,000 | |
Unrealized Losses | (1,085,000) | |
Fair Value | 2,834,940,000 | |
U.S. treasury securities | Cash and Cash Equivalents | ||
Debt Securities, Available-for-Sale [Line Items] | ||
Amortized Cost | 10,078,000 | |
Unrealized Gains | 1,000 | |
Unrealized Losses | 0 | |
Fair Value | 10,079,000 | |
U.S. treasury securities | Current Marketable Securities | ||
Debt Securities, Available-for-Sale [Line Items] | ||
Amortized Cost | 2,821,427,000 | |
Unrealized Gains | 4,519,000 | |
Unrealized Losses | (1,085,000) | |
Fair Value | $ 2,824,861,000 |
Investments and Fair Value Me_5
Investments and Fair Value Measurements - Additional Information (Detail) | 12 Months Ended | 36 Months Ended | ||
Dec. 31, 2023 USD ($) security | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) oz | Dec. 31, 2023 USD ($) security | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Proceeds from sale of available-for-sale securities | $ 694,600,000 | |||
Credit or non-credit losses related to debt securities | 0 | |||
Available-for-sale debt securities in unrealized loss position | $ 236,000,000 | $ 236,000,000 | ||
Number of securities in an unrealized loss position for greater than 12 months | security | 0 | 0 | ||
Debt securities | $ 2,834,940,000 | $ 0 | $ 2,834,940,000 | |
Equity securities received as noncash consideration | 41,700,000 | 6,800,000 | $ 0 | |
Unrealized gain (loss) from equity securities | (159,000,000) | (72,800,000) | ||
Realized loss from equity securities | 113,100,000 | |||
Realized gain (loss) for equity securities | 0 | |||
Privately-held equity securities without readily determinable fair value, amount | 32,600,000 | 24,400,000 | 32,600,000 | |
Revenues | 2,225,012,000 | 1,905,871,000 | 1,541,889,000 | |
Investment in physical commodities | $ 50,900,000 | |||
Weight of commodities purchased | oz | 100 | |||
Proceeds from sales of alternative investments | 51,100,000 | |||
Publicly-Traded Equity Securities Held | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Unrealized gain (loss) from equity securities | (4,500,000) | (197,300,000) | $ (72,800,000) | |
Investment Agreement | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Aggregate purchase price | 0 | $ 124,500,000 | 0 | |
Commercial Contract | Investment Agreement | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Maximum contract value | 376,500,000 | 376,500,000 | ||
Revenues | 87,300,000 | 253,900,000 | ||
Commercial Contract | Investment Agreement | Maximum | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Contractual option amounts | $ 40,400,000 | $ 40,400,000 | ||
Subscription contract term | 7 years | |||
Commercial Contract | Investment Agreement | Minimum | ||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||
Subscription contract term | 2 years |
Balance Sheet Components - Sche
Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Balance Sheet Related Disclosures [Line Items] | ||
Total property and equipment, gross | $ 149,916 | $ 151,582 |
Less: accumulated depreciation and amortization | (102,158) | (82,412) |
Total property and equipment, net | 47,758 | 69,170 |
Leasehold improvements | ||
Balance Sheet Related Disclosures [Line Items] | ||
Total property and equipment, gross | 83,139 | 80,378 |
Computer equipment, software, and other | ||
Balance Sheet Related Disclosures [Line Items] | ||
Total property and equipment, gross | 50,844 | 52,688 |
Furniture and fixtures | ||
Balance Sheet Related Disclosures [Line Items] | ||
Total property and equipment, gross | 13,834 | 13,010 |
Construction in progress | ||
Balance Sheet Related Disclosures [Line Items] | ||
Total property and equipment, gross | $ 2,099 | $ 5,506 |
Balance Sheet Components - Addi
Balance Sheet Components - Additional information (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Balance Sheet Related Disclosures [Abstract] | |||
Depreciation and amortization expense excluding the impact of foreign exchange fluctuations | $ 23.7 | $ 19.5 | $ 12.8 |
Balance Sheet Components - Sc_2
Balance Sheet Components - Schedule of Accrued Liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Balance Sheet Related Disclosures [Abstract] | ||
Accrued payroll and related expenses | $ 83,094 | $ 43,495 |
Accrued taxes | 47,257 | 41,326 |
Accrued other liabilities | 92,640 | 87,894 |
Total accrued liabilities | $ 222,991 | $ 172,715 |
Debt - Additional Information (
Debt - Additional Information (Detail) - 2014 Revolving Credit Facility - Line of Credit | 12 Months Ended |
Dec. 31, 2023 USD ($) | |
Short-Term Debt [Line Items] | |
Debt instrument maximum borrowing capacity | $ 500,000,000 |
Revolving Credit Facility | |
Short-Term Debt [Line Items] | |
Debt instrument carrying amount | 0 |
Line of credit minimum liquidity to be maintained | $ 50,000,000 |
Leases - Additional Information
Leases - Additional Information (Detail) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 USD ($) option | Dec. 31, 2022 | |
Leases [Abstract] | ||
Number of options to extend leases | option | 1 | |
Weighted average remaining lease term (in years) | 6 years | 7 years |
Weighted average discount rate (in percent) | 6% | 6% |
Leases not yet commenced | $ | $ 0 |
Leases - Summary Balance Sheet
Leases - Summary Balance Sheet Information Relating to Leases (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Lease-Related Assets and Liabilities | ||
Operating lease right-of-use assets | $ 182,863 | $ 200,240 |
Total right-of-use assets | 182,863 | 200,240 |
Lease liabilities: | ||
Operating lease liabilities | 54,176 | 45,099 |
Operating lease liabilities, noncurrent | 175,216 | 204,305 |
Total operating lease liabilities | $ 229,392 | $ 249,404 |
Leases - Summary of Operating L
Leases - Summary of Operating Lease Cost (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Lease, Cost [Abstract] | ||
Operating lease expense | $ 61,972 | $ 55,483 |
Short-term lease expense | 4,949 | 4,956 |
Variable lease expense | 4,772 | 5,309 |
Sublease income | (18,905) | (13,011) |
Total lease expense, net | $ 52,788 | $ 52,737 |
Leases - Maturities of Operatin
Leases - Maturities of Operating Lease Liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Operating Lease Commitments | ||
2024 | $ 67,420 | |
2025 | 57,053 | |
2026 | 40,068 | |
2027 | 28,278 | |
2028 | 21,816 | |
Thereafter | 62,116 | |
Total undiscounted liabilities | 276,751 | |
Less: Imputed interest | (47,359) | |
Total operating lease liabilities | 229,392 | $ 249,404 |
Less: Sublease Income | ||
2024 | 16,593 | |
2025 | 14,357 | |
2026 | 13,748 | |
2027 | 14,423 | |
2028 | 12,470 | |
Thereafter | 30,761 | |
Total undiscounted liabilities | 102,352 | |
Less: Imputed interest | 0 | |
Total operating lease liabilities | 102,352 | |
Net Lease Commitments | ||
2024 | 50,827 | |
2025 | 42,696 | |
2026 | 26,320 | |
2027 | 13,855 | |
2028 | 9,346 | |
Thereafter | 31,355 | |
Total undiscounted liabilities | 174,399 | |
Less: Imputed interest | (47,359) | |
Total operating lease liabilities | $ 127,040 |
Leases - Summary of Supplementa
Leases - Summary of Supplemental Cash Flow Information Related to Operating Leases (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Leases [Abstract] | ||
Cash paid for operating lease liabilities | $ 63,374 | $ 53,772 |
Lease liabilities arising from obtaining right-of-use assets | $ 28,112 | $ 28,169 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - Purchase Commitment Two - USD ($) $ in Millions | 1 Months Ended | 12 Months Ended |
Sep. 30, 2023 | Dec. 31, 2023 | |
Purchase Commitment, Excluding Long-Term Commitment [Line Items] | ||
Minimum annual commitment | $ 1,950 | |
Period for purchase price commitment (in years) | 10 years | |
Purchase commitment for current contract year | $ 40.7 | |
Purchase commitment for year one | $ 154 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Detail) | 12 Months Ended | |
Dec. 31, 2023 USD ($) vote shares | Aug. 31, 2023 USD ($) | |
Class of Stock [Line Items] | ||
Minimum ownership threshold (in shares) | shares | 100,000,000 | |
Dividends declared | $ | $ 0 | |
Stock repurchase program, authorized amount | $ | $ 1,000,000,000 | |
Stock repurchased during period (in shares) | shares | 0 | |
Class A Common Stock | ||
Class of Stock [Line Items] | ||
Voting rights | vote | 1 | |
Class B Common Stock | ||
Class of Stock [Line Items] | ||
Voting rights | vote | 10 | |
Common stock, convertible, conversion ratio | 1 | |
Class F Common Stock | ||
Class of Stock [Line Items] | ||
Control of total voting power | 50% |
Stockholders' Equity - Summary
Stockholders' Equity - Summary of Total Authorized, Issued, And Outstanding Shares (Detail) - shares | Dec. 31, 2023 | Dec. 31, 2022 |
Class of Stock [Line Items] | ||
Authorized | 22,701,005,000 | 22,701,005,000 |
Issued | 2,200,128,000 | 2,099,075,000 |
Outstanding | 2,200,128,000 | 2,099,075,000 |
Class A Common Stock | ||
Class of Stock [Line Items] | ||
Authorized | 20,000,000,000 | 20,000,000,000 |
Issued | 2,096,982,000 | 1,995,414,000 |
Outstanding | 2,096,982,000 | 1,995,414,000 |
Class B Common Stock | ||
Class of Stock [Line Items] | ||
Authorized | 2,700,000,000 | 2,700,000,000 |
Issued | 102,141,000 | 102,656,000 |
Outstanding | 102,141,000 | 102,656,000 |
Class F Common Stock | ||
Class of Stock [Line Items] | ||
Authorized | 1,005,000 | 1,005,000 |
Issued | 1,005,000 | 1,005,000 |
Outstanding | 1,005,000 | 1,005,000 |
Stock-Based Compensation - Addi
Stock-Based Compensation - Additional Information (Detail) - USD ($) | 1 Months Ended | 12 Months Ended | |||
Sep. 30, 2020 | Aug. 30, 2020 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Options granted (in shares) | 0 | 0 | 0 | ||
Options vested and exercisable (in years) | 6 years 11 months 4 days | ||||
Aggregate intrinsic value of options exercised | $ 476,800,000 | $ 112,300,000 | $ 3,800,000,000 | ||
Grant date fair value of stock options vested during period | 131,000,000 | 170,800,000 | 189,500,000 | ||
Unrecognized share based compensation expense | $ 599,100,000 | ||||
Unrecognized share based compensation expense, period for recognition (in years) | 7 years | ||||
Tax benefits related to stock-based compensation expense | $ 0 | 0 | 0 | ||
Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share based payment award vesting period | 4 years | ||||
Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Share based payment award vesting period | 1 year | ||||
Restricted Stock Units (RSUs) | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Grants in period (in shares) | 19,484,000 | ||||
Unrecognized share based compensation expense | $ 566,400,000 | ||||
Share based payment award vesting period | 4 years | ||||
Vested in period | $ 526,100,000 | $ 453,200,000 | $ 421,000,000 | ||
Unrecognized share based compensation expense, period for recognition (in years) | 3 years | ||||
P-RSUs | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Grants in period (in shares) | 1,976,000 | ||||
Unrecognized share based compensation expense | $ 0 | ||||
Share based payment award vesting period | 3 months | ||||
P-RSUs | Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Performance target (in percent) | 0% | ||||
P-RSUs | Maximum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Performance target (in percent) | 100% | ||||
2020 Equity Incentive Plan | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Shares reserved for future issuance (in shares) | 150,000,000 | 165,900,000 | |||
Options granted (in shares) | 162,000,000 | ||||
Outstanding stock maximum (in percent) | 5% | ||||
Ownership (in percent) | 10% | ||||
2020 Equity Incentive Plan | Minimum | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Fair value of common stock (in percent) | 110% | ||||
2020 Equity Incentive Plan | Class A Common Stock | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Additional shares authorized (in shares) | 250,000,000 | ||||
Expiration period (in years) | 10 years | ||||
2020 Equity Incentive Plan | Restricted Stock Units (RSUs) | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Grants in period (in shares) | 3,900,000 | ||||
2020 Extended Exercisability | |||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||
Expiration period (in years) | 5 years | ||||
Options vested and exercisable (in years) | 4 years |
Stock-Based Compensation - Summ
Stock-Based Compensation - Summary of Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Options Outstanding | ||
Beginning balance (in shares) | 326,913,000 | |
Options exercised (in shares) | (46,079,000) | |
Options canceled and forfeited (in shares) | (2,364,000) | |
Ending balance (in shares) | 278,470,000 | 326,913,000 |
Options vested and exercisable, end of period (in shares) | 160,877,000 | |
Weighted-Average Exercise Price Per Share | ||
Beginning balance (in dollars per share) | $ 8.05 | |
Options exercised (in dollars per share) | 4.74 | |
Options canceled and forfeited (in dollars per share) | 5.39 | |
Ending balance (in dollars per share) | 8.62 | $ 8.05 |
Options vested and exercisable, end of period (in dollars per share) | $ 6.66 | |
Weighted-Average Remaining Contractual Life (years) and Aggregate Intrinsic Value | ||
Options outstanding, Weighted-average remaining contractual life (in years) | 7 years 7 months 20 days | 8 years 3 months 29 days |
Options vested and exercisable (in years) | 6 years 11 months 4 days | |
Options outstanding, aggregate intrinsic value | $ 2,381,172 | $ 272,603 |
Options vested and exercisable, end of period | $ 1,691,404 |
Stock-Based Compensation - Su_2
Stock-Based Compensation - Summary of RSU And PRSU Activity (Detail) | 12 Months Ended |
Dec. 31, 2023 $ / shares shares | |
RSUs | |
Units Outstanding | |
Unvested and outstanding, beginning balance (in shares) | shares | 126,426,000 |
Granted (in shares) | shares | 19,484,000 |
Vested and converted to shares (in shares) | shares | (54,974,000) |
Canceled (in shares) | shares | (8,674,000) |
Unvested and outstanding, ending balance (in shares) | shares | 82,262,000 |
Weighted Average Grant Date Fair Value per Share | |
Unvested and outstanding, beginning balance (in dollars per share) | $ / shares | $ 10.07 |
Granted (in dollars per share) | $ / shares | 11.77 |
Vested and converted to shares (in dollars per share) | $ / shares | 9.57 |
Cancelled (in dollars per share) | $ / shares | 11.08 |
Unvested and outstanding, ending balance (in dollars per share) | $ / shares | $ 10.71 |
P-RSUs | |
Units Outstanding | |
Unvested and outstanding, beginning balance (in shares) | shares | 0 |
Granted (in shares) | shares | 1,976,000 |
Vested and converted to shares (in shares) | shares | 0 |
Canceled (in shares) | shares | 0 |
Unvested and outstanding, ending balance (in shares) | shares | 1,976,000 |
Weighted Average Grant Date Fair Value per Share | |
Unvested and outstanding, beginning balance (in dollars per share) | $ / shares | $ 0 |
Granted (in dollars per share) | $ / shares | 15.39 |
Vested and converted to shares (in dollars per share) | $ / shares | 0 |
Cancelled (in dollars per share) | $ / shares | 0 |
Unvested and outstanding, ending balance (in dollars per share) | $ / shares | $ 15.39 |
Stock-Based Compensation - Su_3
Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 475,903 | $ 564,798 | $ 778,215 |
Cost of revenue | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 35,995 | 44,061 | 68,546 |
Sales and marketing | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 160,645 | 196,301 | 242,910 |
Research and development | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | 98,064 | 93,871 | 150,298 |
General and administrative | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Total stock-based compensation expense | $ 181,199 | $ 230,565 | $ 316,461 |
Income Taxes - Summary of Loss
Income Taxes - Summary of Loss Before Provision for (benefit from) Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items] | |||
Income (loss) before provision for income taxes | $ 237,091 | $ (361,027) | $ (488,494) |
United States | |||
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items] | |||
Income (loss) before provision for income taxes | 174,637 | (402,834) | (514,200) |
Foreign | |||
Schedule of Income (Loss) before Income Tax, Domestic and Foreign [Line Items] | |||
Income (loss) before provision for income taxes | $ 62,454 | $ 41,807 | $ 25,706 |
Income Taxes - Summary of Provi
Income Taxes - Summary of Provision for (benefit from) Income Taxes (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Current: | |||
Federal | $ 0 | $ 0 | $ 0 |
State | 2,333 | 765 | (88) |
Foreign | 22,189 | 9,476 | (11,343) |
Total current provision | 24,522 | 10,241 | (11,431) |
Deferred: | |||
Federal | 0 | 0 | (111) |
State | 0 | 0 | 0 |
Foreign | (4,806) | (174) | 43,427 |
Deferred income taxes | (4,806) | (174) | 43,316 |
Total provision for income taxes | $ 19,716 | $ 10,067 | $ 31,885 |
Income Taxes - Summary of Recon
Income Taxes - Summary of Reconciliation of Effective Income Tax Rate (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Effective Income Tax Rate Reconciliation, Amount [Abstract] | |||
Expected tax (benefit) at U.S. federal statutory rate | $ 49,789 | $ (75,592) | $ (102,584) |
State income taxes - net of federal benefit | 2,309 | 766 | (88) |
Foreign tax rate differential | 859 | 832 | 870 |
Research and development tax credits | (45,667) | (34,546) | (94,591) |
Stock-based compensation | (79,128) | 1,374 | (817,839) |
Non-deductible officers’ compensation | 34,479 | 40,629 | 428,682 |
Change in valuation allowance | 35,070 | 49,833 | 616,572 |
Base Erosion Anti-Abuse Tax and related elections | 14,700 | 25,200 | 0 |
Taxes withheld at source | 4,378 | 0 | 0 |
Non-deductible expenses | 3,610 | 0 | 0 |
Other | (683) | 1,571 | 863 |
Total provision for income taxes | $ 19,716 | $ 10,067 | $ 31,885 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Contingency [Line Items] | ||||
Total provision for income taxes | $ 19,716 | $ 10,067 | $ 31,885 | |
Valuation allowance | 2,102,251 | 2,051,655 | ||
Valuation allowance, increase (decrease) | 50,600 | 74,100 | ||
Capitalized research and experimental expenses | 214,848 | 70,839 | ||
Outside basis difference | 0 | (6,512) | ||
Unrecognized tax benefits | 112,016 | 81,904 | $ 65,070 | $ 75,557 |
United States | ||||
Income Tax Contingency [Line Items] | ||||
Net operating loss carryforwards | 324,000 | 113,100 | ||
Non-US | ||||
Income Tax Contingency [Line Items] | ||||
Net operating loss carryforwards | 464,700 | |||
California Franchise Tax Board | ||||
Income Tax Contingency [Line Items] | ||||
Deferred tax assets, tax credit carryforwards, research | 99,500 | 91,400 | ||
Domestic Tax Authority | ||||
Income Tax Contingency [Line Items] | ||||
Net operating loss carryforwards | 5,000,000 | 5,600,000 | ||
Operating loss carryforwards, not subject to expiration | 4,200,000 | |||
Deferred tax assets, tax credit carryforwards, research | 290,100 | 230,200 | ||
State and Local Jurisdiction | California Franchise Tax Board | ||||
Income Tax Contingency [Line Items] | ||||
Net operating loss carryforwards | $ 2,500,000 | $ 2,800,000 |
Income Taxes - Summary of Signi
Income Taxes - Summary of Significant Deferred Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Components of Deferred Tax Assets and Liabilities [Abstract] | ||
Net operating loss carryforwards | $ 1,317,684 | $ 1,436,957 |
Capitalized research and experimental expenses | 214,848 | 70,839 |
Reserves and accruals | 99,105 | 76,905 |
Tax credit carryforwards | 277,060 | 226,565 |
Stock-based compensation | 139,419 | 203,735 |
Lease liabilities | 53,902 | 58,056 |
Depreciation and amortization | 14,413 | 29,665 |
Capitalized facilitative expenses | 28,906 | 0 |
Gross deferred tax assets | 2,145,337 | 2,102,722 |
Outside basis difference | 0 | (6,512) |
Acquisition related intangibles | (8,428) | (10,225) |
Right-of-use assets | (42,721) | (46,295) |
Total net deferred tax assets before valuation allowance | 2,094,188 | 2,039,690 |
Valuation allowance | (2,102,251) | (2,051,655) |
Net deferred tax assets (liabilities) | $ (8,063) | $ (11,965) |
Income Taxes - Summary of Rec_2
Income Taxes - Summary of Reconciliation of the Gross Unrecognized Tax Benefits (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Unrecognized tax benefit beginning of year | $ 81,904 | $ 65,070 | $ 75,557 |
Increases in current year tax positions | 14,346 | 5,733 | 19,638 |
Increases in prior year tax positions | 15,766 | 11,497 | 967 |
Decreases in prior year tax positions | 0 | (36) | (30,895) |
Decreases in prior year tax positions due to settlements | 0 | (360) | (197) |
Decreases in prior year tax positions due to lapse of statute of limitations | 0 | 0 | 0 |
Unrecognized tax benefit end of year | $ 112,016 | $ 81,904 | $ 65,070 |
Net Earnings (Loss) Per Share_3
Net Earnings (Loss) Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Numerator | |||
Net income (loss) attributable to common stockholders for diluted net earnings (loss) per share | $ 209,825 | $ (373,705) | $ (520,379) |
Denominator | |||
Weighted-average shares used in computing net earnings (loss) per share, basic (in shares) | 2,147,446 | 2,063,793 | 1,923,617 |
Effect of dilutive shares | 150,481 | 0 | 0 |
Weighted-average shares used in computing net earnings (loss) per share, diluted (in shares) | 2,297,927 | 2,063,793 | 1,923,617 |
Net earnings (loss) per share | |||
Net earnings (loss) per share attributable to common stockholders, basic (in dollars per share) | $ 0.10 | $ (0.18) | $ (0.27) |
Net earnings (loss) per share attributable to common stockholders, diluted (in dollars per share) | $ 0.09 | $ (0.18) | $ (0.27) |
Net Earnings (Loss) Per Share_4
Net Earnings (Loss) Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) - shares shares in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 175,245 | 466,381 | 516,768 |
Options and SARs issued and outstanding | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 162,000 | 326,913 | 349,977 |
RSUs and P-RSUs outstanding | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 13,245 | 126,426 | 153,749 |
Warrants to purchase common stock | |||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | |||
Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 0 | 13,042 | 13,042 |
Segment and Geographic Inform_3
Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | |||
Revenues | $ 2,225,012 | $ 1,905,871 | $ 1,541,889 |
Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Revenues | 2,225,012 | 1,905,871 | 1,541,889 |
Total contribution | $ 1,245,555 | $ 1,035,173 | $ 899,429 |
Contribution margin (in percent) | 56% | 54% | 58% |
Operating Segments | Government | |||
Segment Reporting Information [Line Items] | |||
Revenues | $ 1,222,215 | $ 1,071,776 | $ 897,356 |
Total contribution | $ 724,970 | $ 620,677 | $ 541,883 |
Contribution margin (in percent) | 59% | 58% | 60% |
Operating Segments | Commercial | |||
Segment Reporting Information [Line Items] | |||
Revenues | $ 1,002,797 | $ 834,095 | $ 644,533 |
Total contribution | $ 520,585 | $ 414,496 | $ 357,546 |
Contribution margin (in percent) | 52% | 50% | 55% |
Segment and Geographic Inform_4
Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Segment Reporting Information [Line Items] | |||
Income (loss) from operations | $ 119,966 | $ (161,201) | $ (411,046) |
Total stock-based compensation expense | 475,903 | 564,798 | 778,215 |
Reconciling items | |||
Segment Reporting Information [Line Items] | |||
Income (loss) from operations | 119,966 | (161,201) | (411,046) |
Research and development expenses | 306,560 | 265,808 | 237,189 |
General and administrative expenses | 343,126 | 365,768 | 295,071 |
Total stock-based compensation expense | 475,903 | 564,798 | 778,215 |
Operating Segments | |||
Segment Reporting Information [Line Items] | |||
Total contribution | $ 1,245,555 | $ 1,035,173 | $ 899,429 |
Segment and Geographic Inform_5
Segment and Geographic Information - Summary of Revenue by Geography (Detail) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Disaggregation of Revenue [Line Items] | |||
Revenues | $ 2,225,012 | $ 1,905,871 | $ 1,541,889 |
Geographic Concentration Risk | |||
Disaggregation of Revenue [Line Items] | |||
Revenues | $ 2,225,012 | $ 1,905,871 | $ 1,541,889 |
Geographic Concentration Risk | Revenue Benchmark | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk (in percent) | 100% | 100% | 100% |
Geographic Concentration Risk | Revenue Benchmark | Minimum | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk (in percent) | 10% | 10% | 10% |
United States | Geographic Concentration Risk | |||
Disaggregation of Revenue [Line Items] | |||
Revenues | $ 1,378,247 | $ 1,161,416 | $ 879,156 |
United States | Geographic Concentration Risk | Revenue Benchmark | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk (in percent) | 62% | 61% | 57% |
United Kingdom | Geographic Concentration Risk | |||
Disaggregation of Revenue [Line Items] | |||
Revenues | $ 235,257 | $ 220,942 | $ 173,362 |
United Kingdom | Geographic Concentration Risk | Revenue Benchmark | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk (in percent) | 11% | 12% | 11% |
Rest of world | Geographic Concentration Risk | |||
Disaggregation of Revenue [Line Items] | |||
Revenues | $ 611,508 | $ 523,513 | $ 489,371 |
Rest of world | Geographic Concentration Risk | Revenue Benchmark | |||
Disaggregation of Revenue [Line Items] | |||
Concentration risk (in percent) | 27% | 27% | 32% |
Segment and Geographic Inform_6
Segment and Geographic Information - Summary of Property and Equipment, Net by Geography (Detail) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Property and equipment, net | $ 47,758 | $ 69,170 |
Geographic Concentration Risk | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Property and equipment, net | $ 47,758 | $ 69,170 |
Geographic Concentration Risk | Property, Plant and Equipment | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Concentration risk (in percent) | 100% | 100% |
United States | Geographic Concentration Risk | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Property and equipment, net | $ 28,825 | $ 46,599 |
United States | Geographic Concentration Risk | Property, Plant and Equipment | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Concentration risk (in percent) | 60% | 67% |
Japan | Geographic Concentration Risk | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Property and equipment, net | $ 11,440 | $ 13,318 |
Japan | Geographic Concentration Risk | Property, Plant and Equipment | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Concentration risk (in percent) | 24% | 19% |
United Kingdom | Geographic Concentration Risk | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Property and equipment, net | $ 5,851 | $ 6,746 |
United Kingdom | Geographic Concentration Risk | Property, Plant and Equipment | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Concentration risk (in percent) | 12% | 10% |
Rest of world | Geographic Concentration Risk | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Property and equipment, net | $ 1,642 | $ 2,507 |
Rest of world | Geographic Concentration Risk | Property, Plant and Equipment | ||
Segment Reporting, Other Significant Reconciling Item [Line Items] | ||
Concentration risk (in percent) | 4% | 4% |
Business Combinations - Narrati
Business Combinations - Narrative (Details) - USD ($) | 12 Months Ended | |||
Nov. 08, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Business Acquisition [Line Items] | ||||
Gain from step acquisition | $ 0 | $ 44,306,000 | $ 0 | |
Palantir Technologies Japan, K.K. | ||||
Business Acquisition [Line Items] | ||||
Fair value on acquisition date | $ 149,000,000 | |||
Equity interest immediately prior to the acquisition | 74,500,000 | |||
Noncontrolling interest | 74,500,000 | |||
Recognized identifiable assets acquired and liabilities assumed, cash | 66,700,000 | |||
Goodwill | 36,100,000 | |||
Recognized identifiable assets acquired and liabilities assumed, liabilities | $ 21,000,000 | |||
Goodwill recognized expected to be deductible for income tax purposes | $ 0 | |||
Gain from step acquisition | $ 44,300,000 | |||
Palantir Technologies Japan, K.K. | Minimum | ||||
Business Acquisition [Line Items] | ||||
Amortization period of finite-intangible assets (in years) | 2 years | |||
Palantir Technologies Japan, K.K. | Maximum | ||||
Business Acquisition [Line Items] | ||||
Amortization period of finite-intangible assets (in years) | 7 years | |||
Palantir Technologies Japan, K.K. | Customer Relationships, Reacquired Rights, Backlog | ||||
Business Acquisition [Line Items] | ||||
Recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles | $ 34,700,000 | |||
Palantir Technologies Japan, K.K. | Other | ||||
Business Acquisition [Line Items] | ||||
Recognized identifiable assets acquired and liabilities assumed, finite-lived intangibles | $ 32,500,000 | |||
Palantir Technologies Japan, K.K. | ||||
Business Acquisition [Line Items] | ||||
Ownership percentage (in percent) | 50% |
Intangible Assets - Schedule of
Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] | ||
Gross Carrying Amount | $ 38,943 | $ 40,436 |
Accumulated Amortization | (13,041) | (4,897) |
Total | $ 25,902 | 35,539 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted average useful life | 3 years 9 months 29 days | |
Gross Carrying Amount | $ 10,400 | 10,400 |
Accumulated Amortization | (2,427) | (347) |
Total | $ 7,973 | 10,053 |
Reacquired rights | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted average useful life | 5 years 9 months 29 days | |
Gross Carrying Amount | $ 17,618 | 17,619 |
Accumulated Amortization | (2,936) | (420) |
Total | $ 14,682 | 17,199 |
Backlog | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted average useful life | 9 months 29 days | |
Gross Carrying Amount | $ 6,700 | 6,700 |
Accumulated Amortization | (3,908) | (558) |
Total | $ 2,792 | 6,142 |
Other | ||
Finite-Lived Intangible Assets [Line Items] | ||
Weighted average useful life | 3 months 7 days | |
Gross Carrying Amount | $ 4,225 | 5,717 |
Accumulated Amortization | (3,770) | (3,572) |
Total | $ 455 | $ 2,145 |
Intangible Assets - Narrative (
Intangible Assets - Narrative (Details) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Amortization expense of intangible assets | $ 9.6 | $ 0 |
Intangible Assets - Expected Am
Intangible Assets - Expected Amortization Expense (Details) - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] | ||
2024 | $ 7,844 | |
2025 | 4,597 | |
2026 | 4,597 | |
2027 | 4,250 | |
2028 | 2,517 | |
Thereafter | 2,097 | |
Total | $ 25,902 | $ 35,539 |